Advertisement
Research ArticleIUPHAR Nomenclature Reports

International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin Receptor Nomenclature, Distribution, and Function

Helen R. Kirby, Janet J. Maguire, William H. Colledge and Anthony P. Davenport
Pharmacological Reviews December 2010, 62 (4) 565-578; DOI: https://doi.org/10.1124/pr.110.002774

Abstract

Kisspeptins are members of the Arg-Phe amide family of peptides, which have been identified as endogenous ligands for a G-protein-coupled receptor encoded by a gene originally called GPR54 (also known as AXOR12 or hOT7T175). After this pairing, the gene has been renamed KISS1R. The International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification recommends that the official name for the receptor is the kisspeptin receptor to follow the convention of naming the receptor protein after the endogenous ligand. The endogenous ligand was initially called metastin, after its role as a metastasis suppressor, and is now referred to as kisspeptin-54 (KP-54), a C-terminally amidated 54-amino acid peptide cleaved from the 145-amino acid gene product. Shorter C-terminal cleavage fragments [KP-14, KP-13 and KP-10 (the smallest active fragment)] are also biologically active. Both receptor and peptide are widely expressed in human, rat, and mouse; the receptor sequence shares more than 80% homology in these species. Activation of the kisspeptin receptor by kisspeptin is via coupling to Gq/11 and the phospholipase C pathway, causing Ca2+ mobilization. Mutations in the KISS1R gene result in hypogonadotropic hypogonadotropism, and targeted disruption of Kiss1r in mice reproduces this phenotype, which led to the discovery of the remarkable ability of the kisspeptin receptor to act as a molecular switch for puberty. In addition to regulating the reproductive axis, the kisspeptin receptor is also implicated in cancer, placentation, diabetes, and the cardiovascular system.

I. Introduction

The endogenous ligand of the orphan G-protein-coupled receptor GPR54 was identified in 2001 (Kotani et al., 2001; Muir et al., 2001; Ohtaki et al., 2001) as the product of the KISS1 gene, which was a known metastasis suppressor (Lee et al., 1996; Lee and Welch, 1997a,b). The ligand was initially christened metastin and is now referred to as kisspeptin. The KISS1 gene product consists of 145 amino acids, which is cleaved to produce a C-terminally amidated 54 amino-acid peptide, KP-54. The C-terminal cleavage fragments KP-14, KP-13, and KP-10 also possess biological activity, although it is unclear to what extent these peptides are generated endogenously (Fig. 1). Cleavage of the three C-terminal amino acids of kisspeptin by the matrix-metalloproteases 2 and 9 (MMP-2/9) renders the peptide inactive (Fig. 1) (Takino et al., 2003). High expression levels of both receptor and peptide are present in the placenta, with lower levels in the brain, particularly the hypothalamus and the pituitary.

Fig. 1.
Fig. 1.

Human kisspeptin (KP-54) and the cleavage fragments KP-14 and KP-10. The MMP-2/9 cleavage site is indicated.

The original interest in the kisspeptin system focused on its effects in cancer. However, in 2003, several persons with hypogonadotropic hypogonadism were identified with mutations in the KISS1R gene (Seminara et al., 2003; de Roux et al., 2003). It has since been elucidated in an increasing number of species that kisspeptin, acting at the kisspeptin receptor, is responsible for the regulation of the reproductive axis by integrating internal and external cues. For more detailed information, the reviews listed in Table 1 should be consulted.

View this table:
TABLE 1

Detailed reviews

The standard NC-IUPHAR rules of nomenclature state that a receptor is named after its endogenous agonist (Vanhoutte et al., 1996), and therefore we support the suggestion of others that, at the protein level, GPR54 is referred to as the kisspeptin receptor (http://www.iuphar-db.org/PRODDATABASE/ObjectDisplayForward?objectId=266, Gottsch et al., 2009). They also suggest abbreviating the kisspeptin receptor to KISS1R; however, the use of the letter R in the abbreviation is not consistent with NC-IUPHAR nomenclature (Vanhoutte et al., 1996), although it helps to avoid confusion when referring to KISS1 peptides. Kisspeptin can also be referred to as KP-54, KP-14, KP-13, or KP-10 depending on the length of the fragment. Gene names should be italicized and, consistent with the Human Genome Organization (HUGO), KISS1R refers to the receptor gene and KISS1 to the peptide gene, with lower case letters used for nonhuman species (Table 2).

View this table:
TABLE 2

Nomenclature for kisspeptin and its receptor

II. G-Protein-Coupled Receptor 54 Designated as the Kisspeptin Receptor

Lee et al. (1999) cloned a novel G-protein-coupled receptor from rat brain and identified this as a 396-amino acid polypeptide with the expected seven transmembrane domains. Metastin, the peptide product of the KISS1 gene, was identified as the endogenous ligand for GPR54 by three independent groups (Kotani et al., 2001; Muir et al., 2001; Ohtaki et al., 2001). This peptide ligand was initially termed metastin after its ability to inhibit metastasis and was classified as a member of the Arg-Phe (RF)-amide family, a group that also includes PrRP, QRFP, and NPFF (Kutzleb et al., 2005). The KISS1 gene was named for its place of discovery, Hershey, Pennsylvania, home of the “Hershey's Kisses” sweets. The name incorporated “SS” for suppressor sequence, reflecting its metastatic effects. Following International Union of Pharmacology convention to name receptors after their endogenous agonists, GPR54 should be designated the kisspeptin receptor for the ligand kisspeptin (Table 3).

View this table:
TABLE 3

Classification of the kisspeptin receptor

The kisspeptin receptor is a class A G-protein-coupled receptor coupled to Gq/11, causing activation of the phospholipase C (PLC) signaling pathway and resultant Ca2+ mobilization (see section VII). Rat and human kisspeptin receptors share 85% sequence identity, increasing to 98% in the transmembrane domains, whereas mouse and human share 82% (Fig. 2). The closest structural relative of the kisspeptin receptor is the galanin receptor GAL1, with 45% homology; howeverm galanin does not bind to it (Lee et al., 1999) (Fig. 3). KP-10, consisting of the 10 C-terminal amino acids of the full sequence, is the minimum fragment length needed to bind and activate the kisspeptin receptor, and it has a potency in vitro similar to that of the full-length 54-amino acid peptide (Kotani et al., 2001), although activities after peripheral delivery in vivo are slightly different (Thompson et al., 2006).

Fig. 2.
Fig. 2.

ClustalW (http://www.ebi.ac.uk/clustalw/) sequence alignment of the human, rat and mouse kisspeptin receptor. *, identical amino acid in both species; :, conserved amino acid substitution; ·, semiconserved amino acid substitution; −, break in the sequence.

Fig. 3.
Fig. 3.

Cladogram showing the relationship of the kisspeptin receptor with other receptors. UT, urotensin receptor; GAL1–3, galanin receptors.

III. Kisspeptin Receptor Distribution

A. Human

In humans, reverse transcriptase polymerase chain reaction has revealed high levels of KISS1R mRNA in placenta, pituitary, pancreas, and spinal cord (Kotani et al., 2001; Muir et al., 2001; Ohtaki et al., 2001) (Table 4). Northern blotting detected high KISS1R mRNA peripherally, in the heart, skeletal muscle, kidney, liver, and placenta, and also in regions of the brain (cerebral cortex, putamen, and medulla) and the spinal cord (Clements et al., 2001). Immunohistochemistry confirmed expression in the brain, detecting neuronal expression in the cerebral cortex, thalamus, pons-medulla, and cerebellum (Muir et al., 2001). In the periphery, specific 125I-KP-14 binding was detected in aorta, coronary artery, and umbilical vein (Mead et al., 2007b), suggesting expression of the kisspeptin receptor in the cardiovascular system.

View this table:
TABLE 4

Summary of the distribution of KISS1R mRNA in human compiled from various studies

B. Mouse

In the mouse, Kiss1r mRNA is expressed in the central nervous system (Funes et al., 2003) and particularly in gonadotropin-releasing hormone (GnRH) neurons (Han et al., 2005; Messager et al., 2005b). With the use of X gal histochemistry, whereby β-galactosidase was knocked into the Kiss1r gene, expression has been detected in the dentate gyrus of the hippocampus and in both GnRH neurons and cells in the periventricular region of the posterior hypothalamus but not, interestingly, in the rostral part of the third ventricle or arcuate nucleus (Herbison et al., 2010).

C. Rat

In rat, Kiss1r mRNA has been detected in brain regions such as the pons, midbrain, thalamus, hypothalamus, hippocampus, amygdala, cortex, frontal cortex, and striatum in addition to peripheral regions such the liver and intestine (Lee et al., 1999). Another study also localized Kiss1r mRNA to areas of the brain, including diagonal band of Broca, medial septum, medial preopticarea, lateral preoptic area, median preoptic nucleus, and anterior and lateral hypothalamus (Irwig et al., 2004). Kiss1r mRNA has also been found in the pituitary (Richard et al., 2008).

D. Other Species

Kiss1r mRNA has been detected in the hypothalamus of pig (Li et al., 2008) and monkey (Shahab et al., 2005) and the pituitary of sheep (Smith et al., 2008). There has been recent interest in conservation of the kisspeptin regulation of reproduction during evolution and in keeping with this the kisspeptin receptor has been detected in several fish species, notably in the brain (Parhar et al., 2004; Mohamed et al., 2007; Nocillado et al., 2007; Biran et al., 2008; Filby et al., 2008; van Aerle et al., 2008; Carrillo et al., 2009; Li et al., 2009; Mechaly et al., 2009; Yang et al., 2010) and in frog (Lee et al., 2009; Moon et al., 2009).

IV. Kisspeptin Distribution

A. Human

KISS1 mRNA showed a similar distribution to the receptor, with high levels in placenta, pancreas, testis, liver, and small intestine (Lee et al., 1996; Muir et al., 2001; Ohtaki et al., 2001). More recently, KISS1 mRNA-expressing neurons within the hypothalamus have been identified by in situ hybridization in the infunidibular nucleus (Rometo et al., 2007), the human equivalent of the arcuate nucleus in animals.

B. Mouse

Kisspeptin has been detected at both the mRNA and protein level in several hypothalamic nuclei including the anteroventral periventricular nucleus (AVPV), the preoptic periventricular nucleus (PeN), and the arcuate nucleus (Gottsch et al., 2004; Clarkson and Herbison, 2006), areas implicated in the regulation of gonadotropin secretion. It is noteworthy that levels in the AVPV and PeN are 10-fold higher in female mice than in male mice (Clarkson and Herbison, 2006). The distribution of kisspeptin-immunoreactivity in the mouse brain has been mapped using a well characterized polyclonal rabbit anti-kisspeptin-10 antiserum (AC566) (Franceschini et al., 2006), identifying areas of expression in the arcuate nucleus, the rostral part of the third ventricle, including the AVPV region and in the dorsomedial nucleus and posterior hypothalamus (Clarkson et al., 2009).

C. Rat

Kiss1 mRNA has been detected in the central nervous system and in particular in specific hypothalamic regions, such as the arcuate nucleus, the AVPV, and the PeN (Irwig et al., 2004; Smith et al., 2006b; Adachi et al., 2007; Kauffman et al., 2007b; Kalamatianos et al., 2008). Kiss1 mRNA expression has also been found in the pituitary (Richard et al., 2008). At the protein level, kisspeptin-like immunoreactivity has been identified in the arcuate nucleus and also in the paraventricular and ventromedial nuclei of the hypothalamus (Brailoiu et al., 2005); however, there is some indication that antisera may cross-react with other RF-amide peptides (Colledge, 2009a,b).

D. Other Species

Kisspeptin has been identified in homologous regions of the brain in monkey (Shahab et al., 2005; Shibata et al., 2007; Ramaswamy et al., 2008, 2009), sheep (Estrada et al., 2006; Franceschini et al., 2006; Pompolo et al., 2006), horse (Decourt et al., 2008; Magee et al., 2009), hamster (Paul et al., 2009), goat (Ohkura et al., 2009, and pig (Tomikawa et al., 2010). Kisspeptin has also been found to be expressed in frog (Lee et al., 2009) and fish species (Biran et al., 2008; Felip et al., 2008; Kanda et al., 2008; van Aerle et al., 2008; Carrillo et al., 2009; Kitahashi et al., 2009; Li et al., 2009; Yang et al., 2010), suggesting that the kisspeptin system has been conserved during evolution.

V. Radiolabeled Ligands

Saturation binding analysis, in cells artificially expressing either human or rat KISS1R, has been used to determine dissociation constant, KD, values for 125I-Tyr45-KP-15 (95 pM, human) (Ohtaki et al., 2001) and 125I-KP-10 (1.9 ± 0.4 nM, human; 1.0 ± 0.1 nM, rat) (Kotani et al., 2001). 125I-KP-14 has been characterized in human cardiovascular tissues, where it bound saturably, specifically, and reversibly in human aorta with a KD of 0.20 ± 0.03 nM and a binding density, Bmax, of 7.65 ± 0.95 fmol/mg protein. Binding had an association rate constant (kobs) of 0.164 ± 0.054 min−1, a dissociation rate constant of 0.0020 ± 0.0006 min−1, a half-time (t1/2) for association of 4 min, and t1/2 for dissociation of 301 min (Mead et al., 2007b). Both KP-10 and KP-14 competed monophasically for 125I-kisspeptin-14 binding with KD values of 0.03 ± 0.007 and 0.26 ± 0.12 nM, respectively, suggesting that, together with the Hill slope of 1.12 ± 0.09, there is only one receptor for kisspeptin despite the potential multiple endogenous peptides. Iodinated KP-54 has also been synthesized and used in radioimmunoassays (Dhillo et al., 2005).

VI. Agonists

A. Naturally Occurring Agonists

KP-54, the long isoform of kisspeptin in human, is predicted to be cleaved from the C-terminally amidated KP-145 precursor by furin or prohormone convertases, deduced by the presence of pairs of basic residues flanking this sequence (Kotani et al., 2001; Ohtaki et al., 2001; Harms et al., 2003). The original report describing the isolation of KISS1 mRNA contained a sequencing error (Lee et al., 1996) that introduced a frameshift mutation at amino acid 46 in the precursor peptide and led to a prediction that the resultant protein would consist of 164 amino acids. The corrected sequence, and the corresponding shorter open reading frame of 145 amino acids, was subsequently published (West et al., 1998). In rat and mouse, the long kisspeptin isoform is 52 amino acids long, with Arg-Try-NH2 at the C terminus instead of Arg-Phe-NH2 as in humans (Tena-Sempere 2006a).

Shorter isoforms of kisspeptin, consisting of the 10-, 13-, and 14-amino acid amidated C-terminal sequences, also possess biological activity and have been shown to have potency similar to that of the longer form in vitro (Mead et al., 2007b; Mikkelsen et al., 2009), although a discrepant report exists (Pheng et al., 2009). The shorter isoforms have been reported to have a lower potency in vivo than KP-54 (Thompson et al., 2009), possibly as a result of increased susceptibility to degradation in the circulation. Is it currently not known which of the isoforms of kisspeptin are endogenous or whether the shorter forms are breakdown products, although KP-54, KP-14, and KP-13 have been detected in human placenta (Kotani et al., 2001) and KP-54 in plasma of pregnant women (Horikoshi et al., 2003; Dhillo et al., 2006). In cells artificially expressing the human kisspeptin receptor, KP-13, KP-14, and KP-54 bound with equal affinity (Kotani et al., 2001), and this is reflected in equipotent function of isoforms in native human tissue (Mead et al., 2007b).

B. Synthetic Analogs

A number of studies have attempted to identify the residues that are necessary and sufficient to activate the kisspeptin receptor. Alanine and d-amino acid scans revealed that the five C-terminal amino acids of KP-10 are crucial for agonist activity (Niida et al., 2006). The pharmacophore site has been identified as Phe9, Arg12, and Phe13 of KP-13 (Orsini et al., 2007), with the peptide forming a helicoid conformation from Asn7 to Phe13. The extreme C terminus, the RF moiety, of the receptor seems to be evolutionarily conserved, suggesting that this motif is essential for receptor binding, in agreement with the role of these residues as a pharmacophore. In rat, alanine substitution indicated that residues 6 and 10 of KP-10 are essential for kisspeptin receptor activation, at least in this species (Gutiérrez-Pascual et al., 2009).

The synthesis of lower molecular weight derivatives of the KP-10 structure by 9-fluorenylmethoxycarbonyl-based solid-phase peptide synthesis produced molecules, such as the pentapeptide H-Amb-Nal(2)-Gly-Leu-Arg-Trp-NH2, that were high-potency agonists comparable with kisspeptin (Tomita et al., 2006). Further investigations into the effect of terminal acyl groups on agonist potencies of pentapeptide analogs led to the synthesis of 4-fluorobenzoyl-Phe-Gly-Leu-Arg-Trp-NH2, with an EC50 of 0.69 nM (Tomita et al., 2007). Agonistic peptide analogs of this compound have been synthesized that were more stable against degradation by MMP-2 and -9 (Tomita et al., 2008), which should prove useful in increasing in vivo stability.

A recent structure-activity study revealed that the five N-terminal amino acids of KP-10 are required for receptor activation and also identified key residues, Ser5 and Leu8, that are obligatory for agonist activity. They also found that analogs comprising five amino acids possessed lower binding affinities than those containing the full 10 residues (Roseweir et al., 2009). In addition, a KP-10 analog, [dY]1KP-10, has been reported to be a superagonist in mice in vivo (Curtis et al., 2010). However, previous work by Niida et al. (2006) found no stimulation of the kisspeptin receptor with this analog, which could be due to differences in reporter systems in the two studies.

VII. Antagonists

One peptide antagonist has been reported: ac[(D)-A]NWNGFG[(D)-W]RF (peptide 234) (Roseweir et al., 2009). It was discovered by systematically substituting amino acid residues in the KP-10 sequence and the resulting compounds were tested for the ability to inhibit kisspeptin-stimulated inositol phosphate release against chinese hamster ovary cells stably expressing the kisspeptin receptor. Peptide 234 contained seven residues conserved from KP-10, had an IC50 of 7.0 nM, and competed for the binding of 125I-KP-10 with an affinity of 2.7 nM. It was initially demonstrated to inhibit KP-10 actions on the hypothalamic-gonadotropic axis in female rhesus monkeys, male rats, and ovariectomized ewes upon acute central injections. However, recent studies have documented that both intracerebroventricular and systemic administration of a penetratin-peptide 234 fusion molecule are capable of suppressing gonadotropin secretion after central administration of KP-10 to male rats (Pineda et al., 2010).

VIII. Receptor Signaling

At present, knowledge of intracellular signaling pathways downstream of the kisspeptin receptor has mainly come from assays in cell lines. There is substantial evidence that the kisspeptin receptor couples to the Gαq/11 signaling pathway, activating PLC, to result in phosphatidylinositol 4,5-bisphosphate hydrolysis followed by accumulation of inositol-(1,4,5)-triphosphate and diacylglycerol to cause subsequent Ca2+ mobilization (Kotani et al., 2001; Muir et al., 2001; Ohtaki et al., 2001). Other signaling pathways activated seem to be cell type-dependent, and proposed downstream mediators include protein kinase C, arachidonic acid, mitogen activated protein kinases (such as extracellular signal-regulated kinase 1/2 and p38), and phosphatidylinositol-3-kinase/Akt (Kotani et al., 2001; Muir et al., 2001; Ringel et al., 2002; Becker et al., 2005; Stathatos et al., 2005). Signaling through inositol-(1,4,5)-triphosphate is also consistent with the potential vasoconstrictor role of kisspeptin (see section VIII.C). It is noteworthy that confirmation of kisspeptin signaling via PLC and Ca2+-dependent pathways has been obtained from studies on GnRH neurons in brain slices (Castellano et al., 2006b; Liu et al., 2008), which have also shown involvement of transient receptor potential cation channels (Zhang et al., 2008).

Activation of the kisspeptin receptor by kisspeptins also causes phosphorylation of focal adhesion kinase and paxillin, leading to formation of focal adhesion and stress fibers (Kotani et al., 2001; Ohtaki et al., 2001), and this correlates with the role of kisspeptin in inhibiting chemotaxis. Kisspeptin receptor stimulation has been demonstrated to inhibit calcineurin activity (Stathatos et al., 2005), which could also contribute to metastasis suppression. The kisspeptin receptor pathway seems to have the ability to disrupt signaling via the chemokine receptor CXCR4, thus inhibiting the prometastatic activity arising from interaction with its ligand, stromal cell-derived factor 1 (Navenot et al., 2005). Kisspeptin has been reported to induce apoptosis in cells, although there are conflicting reports about the role apoptosis may play in the metastasis-suppressing actions of kisspeptin (Harms et al., 2003; Becker et al., 2005). However, recent evidence favors an involvement of apoptosis (Navenot et al., 2009b), possibly by activation of Rho and Rho-associated kinase (Navenot et al., 2009a).

Desensitization of the hypothalamic-pituitary-gonadal axis after continuous administration of kisspeptin has been demonstrated (Seminara et al., 2006; Thompson et al., 2006; Ramaswamy et al., 2007; Roa et al., 2008a). Further investigation revealed the kisspeptin receptor to be constitutively associated with the G-protein-coupled receptor serine/threonine kinases and β-arrestins-1 and -2, suggesting that they mediate kisspeptin receptor signaling and desensitization (Pampillo et al., 2009).

The precise mechanism responsible for the inhibitory action of kisspeptin on the expression of MMP-2/9 is not known. However, it is proposed that kisspeptin receptor activation decreases the binding of NFκB binding to the promoter region of MMP-9, affecting its expression and resultant cell migration (Yan et al., 2001).

IX. Physiological Role

A. The Neuroendocrine Regulation of Reproduction

The crucial role that kisspeptin and its receptor play in the regulation of the reproductive axis was first indicated by observations of loss-of-function mutations in the kisspeptin receptor in some patients with idopathic hypogonadotropic hypogonadism (Seminara et al., 2003; de Roux et al., 2003) and confirmed in transgenic mice models (Funes et al., 2003; Seminara et al., 2003; Kauffman et al., 2007c; Lapatto et al., 2007). Kisspeptin has since been identified as a major regulator of the hypothalamic-pituitary-gonadal axis, governing pubertal onset, in an increasing number of species. Kisspeptin is able to stimulate gonadotropin release in humans (Dhillo et al., 2005, 2007), mice (Gottsch et al., 2004; Messager et al., 2005b), rats (Navarro et al., 2004a, 2005a,b; Thompson et al., 2004, 2006), monkeys (Plant et al., 2006; Seminara, 2006), and sheep (Messager et al., 2005b; Caraty et al., 2007). GnRH is a direct mediator of this effect, as shown in monkeys (Keen et al., 2008), sheep (Messager et al., 2005b), pigs (Lents et al., 2008), and goats (Hashizume et al., 2010). GnRH antagonists are able to block kisspeptin-induced release of gonadotropins (Gottsch et al., 2004; Matsui et al., 2004; Navarro et al., 2004a). Further investigations have shown GnRH neurons to express the kisspeptin receptor (Irwig et al., 2004; Parhar et al., 2004; Han et al., 2005; Messager et al., 2005b) and key experiments involving Kiss1r and Kiss1 knockout mice highlighted that a functional kisspeptin receptor is necessary for GnRH secretion and release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) (Seminara et al., 2003; Dungan et al., 2007; Lapatto et al., 2007; d'Anglemont de Tassigny et al., 2007, 2008). Investigations into the mechanism of communication between kisspeptin and GnRH neurons have found that GnRH neuronal activity is increased by kisspeptin, as measured by c-Fos immunoreactivity (Irwig et al., 2004; Matsui et al., 2004), and that kisspeptin depolarizes GnRH neurons (Han et al., 2005; Zhang et al., 2008), increasing firing rates (Quaynor et al., 2007; Dumalska et al., 2008; Liu et al., 2008; Pielecka-Fortuna et al., 2008).

Within the hypothalamus, regulation of the expression of Kiss1 and, to a lesser extent, Kiss1r mRNA by sex steroids has been documented in a range of species. Gonadectomized mice, sheep, and rhesus monkeys show increased Kiss1 mRNA expression in the arcuate nucleus or infundibular region (Irwig et al., 2004; Navarro et al., 2004a; Pompolo et al., 2006 Smith et al., 2005a,b, 2007; Rometo et al., 2007 Shibata et al., 2007). Sex steroid replacement decreases the elevated Kiss1 mRNA expression to control levels (Navarro et al., 2004a; Smith et al., 2005b, 2007; Pompolo et al., 2006; Rometo et al., 2007; Shibata et al., 2007), suggesting that this circuitry represents negative feedback control of gonadotropin secretion. Conversely, the preovulatory LH surge involves positive feedback; in mice and rats, this seems to be regulated by neurons in the AVPV (Smith et al., 2005a, 2006b; Adachi et al., 2007). Ovariectomized female rats have decreased Kiss1 mRNA expression in the AVPV, which is restored with estrogen replacement (Smith et al., 2005a). This seems to be mediated by the estrogen receptor ERα (Kinoshita et al., 2005; Adachi et al., 2007; Roa et al., 2008b,c). However, this mechanism of control varies between species; in sheep and primates, kisspeptin neurons are restricted to the arcuate nucleus and the preoptic area, and both positive and negative feedback regulation of gonadotropin secretion seems to occur in the arcuate nucleus (Estrada et al., 2006; Pompolo et al., 2006; Smith et al., 2007).

There is substantial evidence that kisspeptin receptor signaling is required for the initiation of puberty. Humans and mice with disruption of the KISS1R or KISS1 gene fail to go through puberty (de Roux et al., 2003; Funes et al., 2003; Seminara et al., 2003; d'Anglemont de Tassigny et al., 2007; Lapatto et al., 2007). Kisspeptin administration induced precocious puberty (Navarro et al., 2004b), whereas central injection of a kisspeptin antagonist delayed puberty (Pineda et al., 2010), in prepubertal rats. During puberty, there seems to be increased communication between kisspeptin and GnRH neurons, demonstrated by increased hypothalamic Kiss1 and Kiss1r mRNA expression in rats and monkeys (Navarro et al., 2004a; Shahab et al., 2005), increased appositions between kisspeptin fibers and GnRH neurons (Clarkson and Herbison, 2006), increased kisspeptin pulse frequency (Keen et al., 2008), and increased sensitivity of GnRH neurons to kisspeptin (Han et al., 2005). Kisspeptin may also act at the level of the pituitary, although this is controversial and warrants further investigation (Richard et al., 2009).

A growing body of evidence suggests that the kisspeptin/kisspeptin receptor system has the ability to integrate both metabolic cues, such as nutritional status and metabolism (Castellano et al., 2005; Smith et al., 2006a), and environmental cues such as photoperiod (Greives et al., 2007; Revel et al., 2007; Smith et al., 2007; Wagner et al., 2008) and act on these to affect the reproductive system.

B. Pregnancy

In addition to the well established role of kisspeptin and its receptor in the regulation of the reproductive axis, the kisspeptin system has been proposed to have effects on other physiological systems, such as gestation. Initial reports of kisspeptin expression reported high levels in the human placenta (Lee et al., 1996; Muir et al., 2001; Ohtaki et al., 2001). More specifically, kisspeptin and kisspeptin receptor expression has now been demonstrated in human trophoblasts (Janneau et al., 2002; Bilban et al., 2004), with higher expression in the first trimester than the third, correlating with decreasing invasiveness. An in-house validated radioimmunoassay revealed that in male and nonpregnant female humans, plasma kisspeptin circulates at very low concentrations (Dhillo et al., 2005, 2006). However, during pregnancy, plasma kisspeptin concentrations increase dramatically, with a 1000-fold increase in the first trimester, rising to a 10,000-fold increase in the third trimester (Horikoshi et al., 2003). Kisspeptin inhibits the migration of trophoblasts, at least in vitro (Bilban et al., 2004), possibly via down-regulation of MMP-2. Kiss1 and Kiss1r mRNA expression has also been detected in the trophoblast giant cells of the rat placenta (Terao et al., 2004), although the relevance of kisspeptin in the physiology of gestation of nonhuman species has yet to be fully investigated.

C. Other Roles

In the human cardiovascular system, expression of both receptor and peptide has been identified in the coronary artery, aorta, and umbilical vein, and kisspeptin elicited potent vasoconstrictor effects in coronary artery and umbilical vein (Mead et al., 2007b). In addition, kisspeptin acts as a positive inotropic agent in human and mouse heart (Kirby et al., 2008), consistent with the ability of kisspeptin to increase intracellular Ca2+ (see section VI). This suggests it may function as a cardiovascular transmitter.

In the pancreas, high expression of peptide and receptor has been detected in human and mouse islet endocrine cells, where it can potentiate the secretion of insulin (Hauge-Evans et al., 2006; Bowe et al., 2009). Additional studies suggested that intravenous KP-10 increased insulin levels in rats (Bowe et al., 2009, although another group found that KP-13 reduced glucose-induced insulin secretion in a perfused-pancreas model (Silvestre et al., 2008), a discrepancy that may reflect the different peptides used or the importance of the in vivo environment.

Kiss1 and Kiss1r mRNA have been identified in the rat hippocampus (Arai et al., 2005) and have been shown to affect neuronal transmission there (Arai and Orwig, 2008), presenting the possibility that the kisspeptin system could be involved in neurogenesis, cognition, and the pathogenesis of epilepsy.

X. Pathophysiological Role

A. Metastasis

The initial discovery of kisspeptin was made from observations of an antimetastatic effect of chromosome 6 in human melanoma cell lines (Welch et al., 1994; Miele et al., 1996, 2000). Investigations by subtractive hybridization and differential display showed one gene in particular to be unregulated in those cells transfected with chromosome 6 and that this gene was a metastasis suppressor (Lee et al., 1996; Lee and Welch, 1997a). However, mapping showed that this gene was in fact located on chromosome 1q32, not 6 (Lee et al., 1996). Further studies have determined the presence of a trans-acting regulatory product on chromosome 6 (Lee et al., 1996; West et al., 1998; Goldberg et al., 2003; Mitchell et al., 2007).

The metastatic suppressor activity of the kisspeptin system was first identified in melanoma (Lee and Welch, 1997a; Ohtaki et al., 2001; Shirasaki et al., 2001). It was then shown that this effect was not solely limited to this cancer type by detection in breast cancer (Lee and Welch, 1997b; Martin et al., 2005; Stark et al., 2005; Kostadima et al., 2007; Marot et al., 2007; Mitchell et al., 2007). Most reports associated loss of KISS1 with increasing cancer progression and metastases, although there are contradictions (Martin et al., 2005; Marot et al., 2007). To date, the metastasis suppressor activity of the kisspeptin system has been identified in thyroid (Ringel et al., 2002; Stathatos et al., 2005), ovarian (Jiang et al., 2005; Zhang et al., 2005; Gao et al., 2007; Hata et al., 2007), bladder (Sanchez-Carbayo et al., 2003), gastric (Dhar et al., 2004; Guan-Zhen et al., 2007; Yao et al., 2007), esophageal (Ikeguchi et al., 2004), hepatocellular (Ikeguchi et al., 2003; Hou et al., 2007; Schmid et al., 2007), pancreatic (Masui et al., 2004; Liang and Yang, 2007), and lung (Zohrabian et al., 2007) cancers.

B. Disorders of the Hypothalamic-Pituitary-Gonadal Axis

An understanding of the fundamental role played by the kisspeptin receptor in puberty was achieved from studies of patients with idiopathic hypogonadotropic hypogonadism. Linkage analysis of these patients, who displayed no sexual maturation and low levels of gonadotropins, revealed mutations in the KISS1R gene: a homozygous substitution of leucine to serine at nucleotide 148 (L148S) or heterozygous mutations at nucleotides 331 (R331X) and 399 (X399R) (Seminara et al., 2003). Since then, other loss-of-function mutations have been documented, and more detailed molecular analysis has shown the L148S mutation to inhibit the catalytic activation of Gq but not to affect the trafficking, plasma membrane expression, or ligand binding properties of the receptor (Wacker et al., 2008). A gain-of-function mutation (R386P) has been reported in a girl with central precocious puberty (Teles et al., 2008). The mutations in the kisspeptin receptor that are currently known are illustrated in Fig. 4. It is noteworthy that the phenotype observed in humans carrying loss-of-function mutations was mimicked in Kiss1r-null mice (Seminara et al., 2003), confirming the essential role of the kisspeptin receptor in pubertal development.

Fig. 4.
Fig. 4.

Identified mutations in the human KISS1R gene. [Reprinted from Gianetti E and Seminara S (2008) Kisspeptin and KISS1R: a critical pathway in the reproductive system. Reproduction 136:295–301. Copyright © 2008 Society for Reproduction and Fertility. Used with permission.]

C. Other Pathophysiologies

In concordance with the proposed role of the kisspeptin system in pregnancy, there are emerging, although contradictory, reports of changes in kisspeptin expression in preeclampsia (Qiao et al., 2005; Farina et al., 2006; Armstrong et al., 2009). In addition, Panidis et al. (2006) reported raised levels of KP-54 in normal-weight subjects with polycystic ovary syndrome, which correlates with its association with leptin and obesity. However, these results should be interpreted with caution owing to the different assays used. Kisspeptin and kisspeptin receptor expression has also been detected in human atherosclerotic plaques (Mead et al., 2007b).

In diabetes, where hypogonadism is common, disturbed kisspeptin function can be rescued by leptin (Castellano et al., 2006a). The link between leptin and kisspeptin was further strengthened by observations that leptin can influence the expression of kisspeptin in the arcuate nucleus of mice (Smith et al., 2006a).

XI. Genetically Modified Animals

A. Kisspeptin Receptor

Disruption of the Kiss1r gene in mice results in viable homozygous offspring with hypogonadotropic hypogonadism. Male mice show small testes, hypoplastic Leydig cells, spermatogenic arrest, and absence of development of secondary sex glands. Female mice have delayed vaginal opening, hypoplastic uterine horns, and small ovaries with no graafian follicles or corpora lutea. Both sexes display decreased levels of sex steroids (testosterone or β-estradiol) in addition to reduced concentrations of LH and FSH (Funes et al., 2003; Seminara et al., 2003; Kauffman et al., 2007c; Lapatto et al., 2007), and female mice lack the compensatory rise in LH that usually follows ovariectomy (Dungan et al., 2007). There is also a lack of stimulation of LH or FSH release upon injection of kisspeptin (Messager et al., 2005b). This phenotype is consistent with that of humans with mutations in the KISS1R gene.

B. Kisspeptin

Targeted disruption of the Kiss1 gene also results in viable offspring who have an inability to undergo sexual maturation. Mutant male mice have arrested spermatogenesis and small testes; female mice have small ovaries, threadlike uteri, and no progression through the estrous cycle; and both sexes have low levels of circulating LH, FSH, and sex steroids. The pituitary remains functional, however, as peripheral administration of kisspeptin results in LH secretion (d'Anglemont de Tassigny et al., 2007; Lapatto et al., 2007).

Acknowledgments.

This work was supported by the British Heart Foundation and the UK Medical Research Council [Grants PS/02/001, PG/09/050/27734].

Footnotes

  • This article is available online at http://pharmrev.aspetjournals.org.

    doi:10.1124/pr.110.002774.

  • ↵1 Abbreviations:

    AVPV
    anteroventral periventricular nucleus
    FSH
    follicle-stimulating hormone
    GnRH
    gonadotropin-releasing hormone
    KP
    kisspeptin
    LH
    luteinizing hormone
    MMP
    matrix metalloprotease
    NC-IUPHAR
    Nomenclature Committee, International Union of Basic and Clinical Pharmacology
    PeN
    preoptic periventricular nucleus
    PLC
    phospholipase C.

References

  1. ↵
    1. Adachi S,
    2. Yamada S,
    3. Takatsu Y,
    4. Matsui H,
    5. Kinoshita M,
    6. Takase K,
    7. Sugiura H,
    8. Ohtaki T,
    9. Matsumoto H,
    10. Uenoyama Y,
    11. et al
    . (2007) Involvement of anteroventral periventricular metastin/kisspeptin neurons in estrogen positive feedback action on luteinizing hormone release in female rats. J Reprod Dev 53:367–378.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Arai AC,
    2. Orwig N
    (2008) Factors that regulate KiSS1 gene expression in the hippocampus. Brain Res 1243:10–18.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Arai AC,
    2. Xia YF,
    3. Suzuki E,
    4. Kessler M,
    5. Civelli O,
    6. Nothacker HP
    (2005) Cancer metastasis-suppressing peptide metastin upregulates excitatory synaptic transmission in hippocampal dentate granule cells. J Neurophysiol 94:3648–3652.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Armstrong RA,
    2. Reynolds RM,
    3. Leask R,
    4. Shearing CH,
    5. Calder AA,
    6. Riley SC
    (2009) Decreased serum levels of kisspeptin in early pregnancy are associated with intra-uterine growth restriction and pre-eclampsia. Prenat Diagn 29:982–985.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Becker JA,
    2. Mirjolet JF,
    3. Bernard J,
    4. Burgeon E,
    5. Simons MJ,
    6. Vassart G,
    7. Parmentier M,
    8. Libert F
    (2005) Activation of GPR54 promotes cell cycle arrest and apoptosis of human tumor cells through a specific transcriptional program not shared by other Gq-coupled receptors. Biochem Biophys Res Commun 326:677–686.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Bilban M,
    2. Ghaffari-Tabrizi N,
    3. Hintermann E,
    4. Bauer S,
    5. Molzer S,
    6. Zoratti C,
    7. Malli R,
    8. Sharabi A,
    9. Hiden U,
    10. Graier W,
    11. et al
    . (2004) Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts. J Cell Sci 117:1319–1328.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Biran J,
    2. Ben-Dor S,
    3. Levavi-Sivan B
    (2008) Molecular identification and functional characterization of the kisspeptin/kisspeptin receptor system in lower vertebrates. Biol Reprod 79:776–786.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Bowe JE,
    2. King AJ,
    3. Kinsey-Jones JS,
    4. Foot VL,
    5. Li XF,
    6. O'Byrne KT,
    7. Persaud SJ,
    8. Jones PM
    (2009) Kisspeptin stimulation of insulin secretion: mechanisms of action in mouse islets and rats. Diabetologia 52:855–862.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Brailoiu GC,
    2. Dun SL,
    3. Ohsawa M,
    4. Yin D,
    5. Yang J,
    6. Chang JK,
    7. Brailoiu E,
    8. Dun NJ.,
    9. Chang JK,
    10. Brailoiu E,
    11. Dun NJ
    (2005) KiSS-1 expression and metastin-like immunoreactivity in the rat brain. J Comp Neurol 481:314–329.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Caraty A,
    2. Smith JT,
    3. Lomet D,
    4. Ben Saïd S,
    5. Morrissey A,
    6. Cognie J,
    7. Doughton B,
    8. Baril G,
    9. Briant C,
    10. Clarke IJ
    (2007) Kisspeptin synchronizes preovulatory surges in cyclical ewes and causes ovulation in seasonally acyclic ewes. Endocrinology 148:5258–5267.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Carrillo M,
    2. Zanuy S,
    3. Felip A,
    4. Bayarri MJ,
    5. Molés G,
    6. Gómez A
    (2009) Hormonal and environmental control of puberty in perciform fish: the case of sea bass. Ann NY Acad Sci 1163:49–59.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Castaño JP,
    2. Martínez-Fuentes AJ,
    3. Gutiérrez-Pascual E,
    4. Vaudry H,
    5. Tena-Sempere M,
    6. Malagón MM
    (2009) Intracellular signaling pathways activated by kisspeptins through GPR54: do multiple signals underlie function diversity? Peptides 30:10–15.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Castellano JM,
    2. Gaytan M,
    3. Roa J,
    4. Vigo E,
    5. Navarro VM,
    6. Bellido C,
    7. Dieguez C,
    8. Aguilar E,
    9. Sánchez-Criado JE,
    10. Pellicer A,
    11. Pinilla L,
    12. Gaytan F,
    13. Tena-Sempere M.,
    14. Aguilar E,
    15. Sánchez-Criado JE,
    16. Pellicer A,
    17. Pinilla L,
    18. Gaytan F,
    19. Tena-Sempere M
    (2006a) Expression of KiSS-1 in rat ovary: putative local regulator of ovulation? Endocrinology 147:4852–4862.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Castellano JM,
    2. Navarro VM,
    3. Fernández-Fernández R,
    4. Castaño JP,
    5. Malagón MM,
    6. Aguilar E,
    7. Dieguez C,
    8. Magni P,
    9. Pinilla L,
    10. Tena-Sempere M
    (2006b) Ontogeny and mechanisms of action for the stimulatory effect of kisspeptin on gonadotropin-releasing hormone system of the rat. Mol Cell Endocrinol 257–258:75–83.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Castellano JM,
    2. Navarro VM,
    3. Fernández-Fernández R,
    4. Nogueiras R,
    5. Tovar S,
    6. Roa J,
    7. Vazquez MJ,
    8. Vigo E,
    9. Casanueva FF,
    10. Aguilar E,
    11. et al
    . (2005) Changes in hypothalamic KiSS-1 system and restoration of pubertal activation of the reproductive axis by kisspeptin in undernutrition. Endocrinology 146:3917–3925.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Castellano JM,
    2. Navarro VM,
    3. Roa J,
    4. Pineda R,
    5. Sánchez-Garrido MA,
    6. García-Galiano D,
    7. Vigo E,
    8. Dieguez C,
    9. Aguilar E,
    10. Pinilla L,
    11. et al
    . (2009) Alterations in hypothalamic KiSS-1 system in experimental diabetes: early changes and functional consequences. Endocrinology 150:784–794.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Clarke IJ,
    2. Smith JT,
    3. Caraty A,
    4. Goodman RL,
    5. Lehman MN
    (2009) Kisspeptin and seasonality in sheep. Peptides 30:154–163.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Clarkson J,
    2. d'Anglemont de Tassigny X,
    3. Colledge WH,
    4. Caraty A,
    5. Herbison AE
    (2009) Distribution of kisspeptin neurones in the adult female mouse brain. J Neuroendocrinol 21:673–682.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Clarkson J,
    2. Herbison AE
    (2006) Postnatal development of kisspeptin neurons in mouse hypothalamus; sexual dimorphism and projections to gonadotropin-releasing hormone neurons. Endocrinology 147:5817–5825.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Clements MK,
    2. McDonald TP,
    3. Wang R,
    4. Xie G,
    5. O'Dowd BF,
    6. George SR,
    7. Austin CP,
    8. Liu Q
    (2001) FMRFamide-related neuropeptides are agonists of the orphan G-protein-coupled receptor GPR54. Biochem Biophys Res Commun 284:1189–1193.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Colledge WH
    (2009a) Kisspeptins and GnRH neuronal signalling. Trends Endocrinol Metab 20:115–121.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Colledge WH
    (2009b) Transgenic mouse models to study Gpr54/kisspeptin physiology. Peptides 30:34–41.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Curtis AE,
    2. Cooke JH,
    3. Baxter JE,
    4. Parkinson JR,
    5. Bataveljic A,
    6. Ghatei MA,
    7. Bloom SR,
    8. Murphy KG
    (2010) A kisspeptin-10 analog with greater in vivo bioactivity than kisspeptin-10. Am J Physiol Endocrinol Metab 298:E296–E303.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. d'Anglemont de Tassigny X,
    2. Fagg LA,
    3. Carlton MB,
    4. Colledge WH
    (2008) Kisspeptin can stimulate gonadotropin-releasing hormone (GnRH) release by a direct action at GnRH nerve terminals. Endocrinology 149:3926–3932.
    OpenUrlCrossRefPubMed
  25. ↵
    1. d'Anglemont de Tassigny X,
    2. Fagg LA,
    3. Dixon JP,
    4. Day K,
    5. Leitch HG,
    6. Hendrick AG,
    7. Zahn D,
    8. Franceschini I,
    9. Caraty A,
    10. Carlton MB,
    11. et al
    . (2007) Hypogonadotropic hypogonadism in mice lacking a functional Kiss1 gene. Proc Natl Acad Sci USA 104:10714–10719.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. de Roux N,
    2. Genin E,
    3. Carel JC,
    4. Matsuda F,
    5. Chaussain JL,
    6. Milgrom E
    (2003) Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 100:10972–10976.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Decourt C,
    2. Tillet Y,
    3. Caraty A,
    4. Franceschini I,
    5. Briant C
    (2008) Kisspeptin immunoreactive neurons in the equine hypothalamus Interactions with GnRH neuronal system. J Chem Neuroanat 36:131–137.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Dhar DK,
    2. Naora H,
    3. Kubota H,
    4. Maruyama R,
    5. Yoshimura H,
    6. Tonomoto Y,
    7. Tachibana M,
    8. Ono T,
    9. Otani H,
    10. Nagasue N
    (2004) Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma. Int J Cancer 111:868–872.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Dhillo WS,
    2. Chaudhri OB,
    3. Patterson M,
    4. Thompson EL,
    5. Murphy KG,
    6. Badman MK,
    7. McGowan BM,
    8. Amber V,
    9. Patel S,
    10. Ghatei MA,
    11. et al
    . (2005) Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab 90:6609–6615.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Dhillo WS,
    2. Chaudhri OB,
    3. Thompson EL,
    4. Murphy KG,
    5. Patterson M,
    6. Ramachandran R,
    7. Nijher GK,
    8. Amber V,
    9. Kokkinos A,
    10. Donaldson M,
    11. et al
    . (2007) Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. J Clin Endocrinol Metab 92:3958–3966.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Dhillo WS,
    2. Savage P,
    3. Murphy KG,
    4. Chaudhri OB,
    5. Patterson M,
    6. Nijher GM,
    7. Foggo VM,
    8. Dancey GS,
    9. Mitchell H,
    10. Seckl MJ,
    11. et al
    . (2006) Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment. Am J Physiol Endocrinol Metab 291:E878–E884.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    1. Dumalska I,
    2. Wu M,
    3. Morozova E,
    4. Liu R,
    5. van den Pol A,
    6. Alreja M
    (2008) Excitatory effects of the puberty-initiating peptide kisspeptin and group I metabotropic glutamate receptor agonists differentiate two distinct subpopulations of gonadotropin-releasing hormone neurons. J Neurosci 28:8003–8013.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. Dungan HM,
    2. Gottsch ML,
    3. Zeng H,
    4. Gragerov A,
    5. Bergmann JE,
    6. Vassilatis DK,
    7. Clifton DK,
    8. Steiner RA
    (2007) The role of kisspeptin-GPR54 signaling in the tonic regulation and surge release of gonadotropin-releasing hormone/luteinizing hormone. J Neurosci 27:12088–12095.
    OpenUrlAbstract/FREE Full Text
  34. ↵
    1. Estrada KM,
    2. Clay CM,
    3. Pompolo S,
    4. Smith JT,
    5. Clarke IJ
    (2006) Elevated KiSS-1 expression in the arcuate nucleus prior to the cyclic preovulatory gonadotrophin-releasing hormone/lutenising hormone surge in the ewe suggests a stimulatory role for kisspeptin in oestrogen-positive feedback. J Neuroendocrinol 18:806–809.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Farina A,
    2. Sekizawa A,
    3. Purwosunu Y,
    4. Rizzo N,
    5. Banzola I,
    6. Concu M,
    7. Morano D,
    8. Giommi F,
    9. Bevini M,
    10. Mabrook M,
    11. et al
    . (2006) Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls. Prenat Diagn 26:1115–1120.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Felip A,
    2. Zanuy S,
    3. Pineda R,
    4. Pinilla L,
    5. Carrillo M,
    6. Tena-Sempere M,
    7. Gómez A
    (2008) Evidence for two distinct KiSS genes in non-placental vertebrates that encode kisspeptins with different gonadotropin-releasing activities in fish and mammals. Mol Cell Endocrinol 312:61–71.
    OpenUrlPubMed
  37. ↵
    1. Filby AL,
    2. van Aerle R,
    3. Duitman J,
    4. Tyler CR
    (2008) The kisspeptin/gonadotropin-releasing hormone pathway and molecular signaling of puberty in fish. Biol Reprod 78:278–289.
    OpenUrlAbstract/FREE Full Text
  38. ↵
    1. Franceschini I,
    2. Lomet D,
    3. Cateau M,
    4. Delsol G,
    5. Tillet Y,
    6. Caraty A
    (2006) Kisspeptin immunoreactive cells of the ovine preoptic area and arcuate nucleus co-express estrogen receptor alpha. Neurosci Lett 401:225–230.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Funes S,
    2. Hedrick JA,
    3. Vassileva G,
    4. Markowitz L,
    5. Abbondanzo S,
    6. Golovko A,
    7. Yang S,
    8. Monsma FJ,
    9. Gustafson EL
    (2003) The KiSS-1 receptor GPR54 is essential for the development of the murine reproductive system. Biochem Biophys Res Commun 312:1357–1363.
    OpenUrlCrossRefPubMed
  40. ↵
    1. Gao GL,
    2. Liu LD,
    3. Zou XS,
    4. Chen WX
    (2007) [Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour.] Zhonghua Fu Chan Ke Za Zhi 42:34–38.
    OpenUrlPubMed
    1. Gianetti E,
    2. Seminara S
    (2008) Kisspeptin and KISS1R: a critical pathway in the reproductive system. Reproduction 136:295–301.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    1. Goldberg SF,
    2. Miele ME,
    3. Hatta N,
    4. Takata M,
    5. Paquette-Straub C,
    6. Freedman LP,
    7. Welch DR
    (2003) Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res 63:432–440.
    OpenUrlAbstract/FREE Full Text
  43. ↵
    1. Gottsch ML,
    2. Cunningham MJ,
    3. Smith JT,
    4. Popa SM,
    5. Acohido BV,
    6. Crowley WF,
    7. Seminara S,
    8. Clifton DK,
    9. Steiner RA
    (2004) A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology 145:4073–4077.
    OpenUrlCrossRefPubMed
  44. ↵
    1. Gottsch ML,
    2. Clifton DK,
    3. Steiner RA
    (2009) From KISS1 to kisspeptins: An historical perspective and suggested nomenclature. Peptides 30:4–9.
    OpenUrlCrossRefPubMed
  45. ↵
    1. Greives TJ,
    2. Mason AO,
    3. Scotti MA,
    4. Levine J,
    5. Ketterson ED,
    6. Kriegsfeld LJ,
    7. Demas GE
    (2007) Environmental control of kisspeptin: implications for seasonal reproduction. Endocrinology 148:1158–1166.
    OpenUrlCrossRefPubMed
  46. ↵
    1. Guan-Zhen Y,
    2. Ying C,
    3. Can-Rong N,
    4. Guo-Dong W,
    5. Jian-Xin Q,
    6. Jie-Jun W
    (2007) Reduced protein expression of metastasis-related genes (nm23, KISS1, KAI1 and p53) in lymph node and liver metastases of gastric cancer. Int J Exp Pathol 88:175–183.
    OpenUrlCrossRefPubMed
  47. ↵
    1. Gutiérrez-Pascual E,
    2. Leprince J,
    3. Martínez-Fuentes AJ,
    4. Ségalas-Milazzo I,
    5. Pineda R,
    6. Roa J,
    7. Duran-Prado M,
    8. Guilhaudis L,
    9. Desperrois E,
    10. Lebreton A,
    11. et al
    . (2009) In vivo and in vitro structure-activity relationships and structural conformation of Kisspeptin-10-related peptides. Mol Pharmacol 76:58–67.
    OpenUrlAbstract/FREE Full Text
  48. ↵
    1. Han SK,
    2. Gottsch ML,
    3. Lee KJ,
    4. Popa SM,
    5. Smith JT,
    6. Jakawich SK,
    7. Clifton DK,
    8. Steiner RA,
    9. Herbison AE
    (2005) Activation of gonadotropin-releasing hormone neurons by kisspeptin as a neuroendocrine switch for the onset of puberty. J Neurosci 25:11349–11356.
    OpenUrlAbstract/FREE Full Text
  49. ↵
    1. Harms JF,
    2. Welch DR,
    3. Miele ME
    (2003) KISS1 metastasis suppression and emergent pathways. Clin Exp Metastasis 20:11–18.
    OpenUrlCrossRefPubMed
  50. ↵
    1. Hashizume T,
    2. Saito H,
    3. Sawada T,
    4. Yaegashi T,
    5. Ezzat AA,
    6. Sawai K,
    7. Yamashita T
    (2010) Characteristics of stimulation of gonadotropin secretion by kisspeptin-10 in female goats. Anim Reprod Sci 118:37–41.
    OpenUrlCrossRefPubMed
  51. ↵
    1. Hata K,
    2. Dhar DK,
    3. Watanabe Y,
    4. Nakai H,
    5. Hoshiai H
    (2007) Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer. European Journal of Cancer 43:1452–1459.
    OpenUrlCrossRefPubMed
  52. ↵
    1. Hauge-Evans AC,
    2. Richardson CC,
    3. Milne HM,
    4. Christie MR,
    5. Persaud SJ,
    6. Jones PM
    (2006) A role for kisspeptin in islet function. Diabetologia 49:2131–2135.
    OpenUrlCrossRefPubMed
  53. ↵
    1. Herbison AE,
    2. de Tassigny X,
    3. Doran J,
    4. Colledge WH
    (2010) Distribution and postnatal development of Gpr54 gene expression in mouse brain and gonadotropin-releasing hormone neurons. Endocrinology 151:312–321.
    OpenUrlCrossRefPubMed
  54. ↵
    1. Hori A,
    2. Honda S,
    3. Asada M,
    4. Ohtaki T,
    5. Oda K,
    6. Watanabe T,
    7. Shintani Y,
    8. Yamada T,
    9. Suenaga M,
    10. Kitada C,
    11. et al
    . (2001) Metastin suppresses the motility and growth of CHO cells transfected with its receptor. Biochem Biophys Res Commun 286:958–963.
    OpenUrlCrossRefPubMed
  55. ↵
    1. Horikoshi Y,
    2. Matsumoto H,
    3. Takatsu Y,
    4. Ohtaki T,
    5. Kitada C,
    6. Usuki S,
    7. Fujino M
    (2003) Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab 88:914–919.
    OpenUrlCrossRefPubMed
  56. ↵
    1. Hou YK,
    2. Wang Y,
    3. Cong WM,
    4. Wu MC
    (2007) [Expression of tumor metastasis-suppressor gene KiSS-1 and matrix metalloproteinase-9 in portal vein tumor thrombus of hepatocellular carcinoma.] Ai Zheng 26:591–595.
    OpenUrlPubMed
  57. ↵
    1. Ikeguchi M,
    2. Hirooka Y,
    3. Kaibara N
    (2003) Quantitative reverse transcriptase polymerase chain reaction analysis for KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in hepatocellular carcinoma. J Cancer Res Clin Oncol 129:531–535.
    OpenUrlCrossRefPubMed
  58. ↵
    1. Ikeguchi M,
    2. Yamaguchi K,
    3. Kaibara N
    (2004) Clinical significance of the loss of KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in esophageal squamous cell carcinoma. Clin Cancer Res 10:1379–1383.
    OpenUrlAbstract/FREE Full Text
  59. ↵
    1. Irwig MS,
    2. Fraley GS,
    3. Smith JT,
    4. Acohido BV,
    5. Popa SM,
    6. Cunningham MJ,
    7. Gottsch ML,
    8. Clifton DK,
    9. Steiner RA
    (2004) Kisspeptin activation of gonadotropin releasing hormone neurons and regulation of KiSS-1 mRNA in the male rat. Neuroendocrinology 80:264–272.
    OpenUrlCrossRefPubMed
  60. ↵
    1. Janneau JL,
    2. Maldonado-Estrada J,
    3. Tachdjian G,
    4. Miran I,
    5. Motté N,
    6. Saulnier P,
    7. Sabourin JC,
    8. Coté JF,
    9. Simon B,
    10. Frydman R,
    11. et al
    . (2002) Transcriptional expression of genes involved in cell invasion and migration by normal and tumoral trophoblast cells. J Clin Endocrinol Metab 87:5336–5339.
    OpenUrlCrossRefPubMed
  61. ↵
    1. Jiang T,
    2. Zhang SL,
    3. Lin B,
    4. Meng LR,
    5. Gao H
    (2005) Expression and clinical significance of KISS-1 and GPR54 mRNA in endometrial carcinoma. Zhonghua Zhong Liu Za Zhi 27:229–231.
    OpenUrlPubMed
  62. ↵
    1. Kalamatianos T,
    2. Grimshaw SE,
    3. Poorun R,
    4. Hahn JD,
    5. Coen CW
    (2008) Fasting reduces KiSS-1 expression in the anteroventral periventricular nucleus (AVPV): effects of fasting on the expression of KiSS-1 and neuropeptide Y in the AVPV or arcuate nucleus of female rats. J Neuroendocrinol 20:1089–1097.
    OpenUrlCrossRefPubMed
  63. ↵
    1. Kanda S,
    2. Akazome Y,
    3. Matsunaga T,
    4. Yamamoto N,
    5. Yamada S,
    6. Tsukamura H,
    7. Maeda K,
    8. Oka Y
    (2008) Identification of KiSS-1 product kisspeptin and steroid-sensitive sexually dimorphic kisspeptin neurons in medaka (oryzias latipes). Endocrinology 149:2467–2476.
    OpenUrlCrossRefPubMed
  64. ↵
    1. Kauffman AS,
    2. Clifton DK,
    3. Steiner RA
    (2007a) Emerging ideas about kisspeptin-GPR54 signaling in the neuroendocrine regulation of reproduction. Trends Neurosci 30:504–511.
    OpenUrlCrossRefPubMed
  65. ↵
    1. Kauffman AS,
    2. Gottsch ML,
    3. Roa J,
    4. Byquist AC,
    5. Crown A,
    6. Clifton DK,
    7. Hoffman GE,
    8. Steiner RA,
    9. Tena-Sempere M
    (2007b) Sexual differentiation of Kiss1 gene expression in the brain of the rat. Endocrinology 148:1774–1783.
    OpenUrlCrossRefPubMed
  66. ↵
    1. Kauffman AS,
    2. Park JH,
    3. McPhie-Lalmansingh AA,
    4. Gottsch ML,
    5. Bodo C,
    6. Hohmann JG,
    7. Pavlova MN,
    8. Rohde AD,
    9. Clifton DK,
    10. Steiner RA,
    11. et al
    . (2007c) The kisspeptin receptor GPR54 is required for sexual differentiation of the brain and behavior. J Neurosci 27:8826–8835.
    OpenUrlAbstract/FREE Full Text
  67. ↵
    1. Keen KL,
    2. Wegner FH,
    3. Bloom SR,
    4. Ghatei MA,
    5. Terasawa E
    (2008) An increase in kisspeptin-54 release occurs with the pubertal increase in luteinizing hormone-releasing hormone-1 release in the stalk-median eminence of female rhesus monkeys in vivo. Endocrinology 149:4151–4157.
    OpenUrlCrossRefPubMed
  68. ↵
    1. Kinoshita M,
    2. Tsukamura H,
    3. Adachi S,
    4. Matsui H,
    5. Uenoyama Y,
    6. Iwata K,
    7. Yamada S,
    8. Inoue K,
    9. Ohtaki T,
    10. Matsumoto H,
    11. et al
    . (2005) Involvement of central metastin in the regulation of preovulatory luteinizing hormone surge and estrous cyclicity in female rats. Endocrinology 146:4431–4436.
    OpenUrlCrossRefPubMed
  69. ↵
    1. Kirby H,
    2. Mead E,
    3. Maguire J,
    4. Pitkin S,
    5. Colledge W,
    6. d'Anglemont de Tassigny X,
    7. Davenport A
    (2008) Kisspeptins as inotropic agents in human and mouse heart. Proc Physiol Soc 11:PC152.
    OpenUrl
  70. ↵
    1. Kitahashi T,
    2. Ogawa S,
    3. Parhar IS
    (2009) Cloning and expression of kiss2 in the zebrafish and medaka. Endocrinology 150:821–831.
    OpenUrlCrossRefPubMed
  71. ↵
    1. Kostadima L,
    2. Pentheroudakis G,
    3. Pavlidis N
    (2007) The missing kiss of life: transcriptional activity of the metastasis suppressor gene KiSS1 in early breast cancer. Anticancer Res 27:2499–2504.
    OpenUrlAbstract/FREE Full Text
  72. ↵
    1. Kotani M,
    2. Detheux M,
    3. Vandenbogaerde A,
    4. Communi D,
    5. Vanderwinden JM,
    6. Le Poul E,
    7. Brézillon S,
    8. Tyldesley R,
    9. Suarez-Huerta N,
    10. Vandeput F,
    11. et al
    . (2001) The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 276:34631–34636.
    OpenUrlAbstract/FREE Full Text
  73. ↵
    1. Kuohung W,
    2. Kaiser UB
    (2006) GPR54 and KiSS-1: role in the regulation of puberty and reproduction. Rev Endocr Metab Disord 7:257–263.
    OpenUrlCrossRefPubMed
  74. ↵
    1. Kutzleb C,
    2. Busmann A,
    3. Wendland M,
    4. Maronde E
    (2005) Discovery of novel regulatory peptides by reverse pharmacology: spotlight on chemerin and the RF-amide peptides metastin and QRFP. Curr Protein Pept Sci 6:265–278.
    OpenUrlCrossRefPubMed
  75. ↵
    1. Lapatto R,
    2. Pallais JC,
    3. Zhang D,
    4. Chan YM,
    5. Mahan A,
    6. Cerrato F,
    7. Le WW,
    8. Hoffman GE,
    9. Seminara SB
    (2007) Kiss1−/− mice exhibit more variable hypogonadism than Gpr54−/− mice. Endocrinology 148:4927–4936.
    OpenUrlCrossRefPubMed
  76. ↵
    1. Lee DK,
    2. Nguyen T,
    3. O'Neill GP,
    4. Cheng R,
    5. Liu Y,
    6. Howard AD,
    7. Coulombe N,
    8. Tan CP,
    9. Tang-Nguyen AT,
    10. George SR,
    11. et al
    . (1999) Discovery of a receptor related to the galanin receptors. FEBS Lett 446:103–107.
    OpenUrlCrossRefPubMed
  77. ↵
    1. Lee JH,
    2. Miele ME,
    3. Hicks DJ,
    4. Phillips KK,
    5. Trent JM,
    6. Weissman BE,
    7. Welch DR
    (1996) KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. Journal of the National Cancer Institute 88:1731–1737.
    OpenUrlAbstract/FREE Full Text
  78. ↵
    1. Lee JH,
    2. Welch DR
    (1997a) Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display. Int J Cancer 71:1035–1044.
    OpenUrlCrossRefPubMed
  79. ↵
    1. Lee JH,
    2. Welch DR
    (1997b) Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res 57:2384–2387.
    OpenUrlAbstract/FREE Full Text
  80. ↵
    1. Lee YR,
    2. Tsunekawa K,
    3. Moon MJ,
    4. Um HN,
    5. Hwang JI,
    6. Osugi T,
    7. Otaki N,
    8. Sunakawa Y,
    9. Kim K,
    10. Vaudry H,
    11. et al
    . (2009) Molecular evolution of multiple forms of kisspeptins and GPR54 receptors in vertebrates. Endocrinology 150:2837–2846.
    OpenUrlCrossRefPubMed
  81. ↵
    1. Lents CA,
    2. Heidorn NL,
    3. Barb CR,
    4. Ford JJ
    (2008) Central and peripheral administration of kisspeptin activates gonadotropin but not somatotropin secretion in prepubertal gilts. Reproduction 135:879–887.
    OpenUrlAbstract/FREE Full Text
  82. ↵
    1. Li D,
    2. Yu W,
    3. Liu M
    (2009) Regulation of KiSS1 gene expression. Peptides 30:130–138.
    OpenUrlCrossRefPubMed
  83. ↵
    1. Li S,
    2. Ren J,
    3. Yang G,
    4. Guo Y,
    5. Huang L
    (2008) Characterization of the porcine Kisspeptins receptor gene and evaluation as candidate for timing of puberty in sows. J Anim Breed Genet 125:219–227.
    OpenUrlCrossRefPubMed
  84. ↵
    1. Liang S,
    2. Yang ZL
    (2007) [Expression of KiSS-1mRNA in pancreatic ductal adenocarcinoma and non-cancerous pancreatic tissues in SD rats.] Zhong Nan Da Xue Xue Bao Yi Xue Ban 32:109–113.
    OpenUrlPubMed
  85. ↵
    1. Liu X,
    2. Lee K,
    3. Herbison AE
    (2008) Kisspeptin excites gonadotropin-releasing hormone neurons through a phospholipase C/calcium-dependent pathway regulating multiple ion channels. Endocrinology 149:4605–4614.
    OpenUrlCrossRefPubMed
  86. ↵
    1. Magee C,
    2. Foradori CD,
    3. Bruemmer JE,
    4. Arreguin-Arevalo JA,
    5. McCue PM,
    6. Handa RJ,
    7. Squires EL,
    8. Clay CM
    (2009) Biological and anatomical evidence for kisspeptin regulation of the hypothalamic-pituitary-gonadal axis of estrous horse mares. Endocrinology 150:2813–2821.
    OpenUrlCrossRefPubMed
  87. ↵
    1. Marot D,
    2. Bieche I,
    3. Aumas C,
    4. Esselin S,
    5. Bouquet C,
    6. Vacher S,
    7. Lazennec G,
    8. Perricaudet M,
    9. Kuttenn F,
    10. Lidereau R,
    11. et al
    . (2007) High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors. Endocr Relat Cancer 14:691–702.
    OpenUrlAbstract/FREE Full Text
  88. ↵
    1. Martin TA,
    2. Watkins G,
    3. Jiang WG
    (2005) KiSS-1 expression in human breast cancer. Clin Exp Metastasis 22:503–511.
    OpenUrlCrossRefPubMed
  89. ↵
    1. Masui T,
    2. Doi R,
    3. Mori T,
    4. Toyoda E,
    5. Koizumi M,
    6. Kami K,
    7. Ito D,
    8. Peiper SC,
    9. Broach JR,
    10. Oishi S,
    11. et al
    . (2004) Metastin and its variant forms suppress migration of pancreatic cancer cells. Biochem Biophys Res Commun 315:85–92.
    OpenUrlCrossRefPubMed
  90. ↵
    1. Matsui H,
    2. Takatsu Y,
    3. Kumano S,
    4. Matsumoto H,
    5. Ohtaki T
    (2004) Peripheral administration of metastin induces marked gonadotropin release and ovulation in the rat. Biochem Biophys Res Commun 320:383–388.
    OpenUrlCrossRefPubMed
  91. ↵
    1. Mead EJ,
    2. Maguire JJ,
    3. Kuc RE,
    4. Davenport AP
    (2007a) Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system. Br J Pharmacol 151:1143–1153.
    OpenUrlCrossRefPubMed
  92. ↵
    1. Mead EJ,
    2. Maguire JJ,
    3. Kuc RE,
    4. Davenport AP
    (2007b) Kisspeptins are novel potent vasoconstrictors in humans, with a discrete localization of their receptor, G protein-coupled receptor 54, to atherosclerosis-prone vessels. Endocrinology 148:140–147.
    OpenUrlCrossRefPubMed
  93. ↵
    1. Mechaly AS,
    2. Viñas J,
    3. Piferrer F
    (2009) Identification of two isoforms of the Kisspeptin-1 receptor (kiss1r) generated by alternative splicing in a modern teleost, the Senegalese sole (Solea senegalensis). Biol Reprod 80:60–69.
    OpenUrlAbstract/FREE Full Text
  94. ↵
    1. Messager S
    (2005a) Kisspeptin and its receptor: new gatekeepers of puberty. J Neuroendocrinol 17:687–688.
    OpenUrlCrossRefPubMed
  95. ↵
    1. Messager S,
    2. Chatzidaki EE,
    3. Ma D,
    4. Hendrick AG,
    5. Zahn D,
    6. Dixon J,
    7. Thresher RR,
    8. Malinge I,
    9. Lomet D,
    10. Carlton MB,
    11. et al
    . (2005b) Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proc Natl Acad Sci USA 102:1761–1766.
    OpenUrlAbstract/FREE Full Text
  96. ↵
    1. Miele ME,
    2. Jewett MD,
    3. Goldberg SF,
    4. Hyatt DL,
    5. Morelli C,
    6. Gualandi F,
    7. Rimessi P,
    8. Hicks DJ,
    9. Weissman BE,
    10. Barbanti-Brodano G,
    11. et al
    . (2000) A human melanoma metastasis-suppressor locus maps to 6q16.3-q23. Int J Cancer 86:524–528.
    OpenUrlCrossRefPubMed
  97. ↵
    1. Miele ME,
    2. Robertson G,
    3. Lee JH,
    4. Coleman A,
    5. McGary CT,
    6. Fisher PB,
    7. Lugo TG,
    8. Welch DR
    (1996) Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6. Mol Carcinog 15:284–299.
    OpenUrlCrossRefPubMed
  98. ↵
    1. Mikkelsen JD,
    2. Bentsen AH,
    3. Ansel L,
    4. Simonneaux V,
    5. Juul A
    (2009) Comparison of the effects of peripherally administered kisspeptins. Regul Pept 152:95–100.
    OpenUrlCrossRefPubMed
  99. ↵
    1. Mitchell DC,
    2. Stafford LJ,
    3. Li D,
    4. Bar-Eli M,
    5. Liu M
    (2007 Transcriptional regulation of KiSS-1 gene expression in metastatic melanoma by specificity protein-1 and its coactivator DRIP-130. Oncogene 26:1739–1747.
    OpenUrlCrossRefPubMed
  100. ↵
    1. Mohamed JS,
    2. Benninghoff AD,
    3. Holt GJ,
    4. Khan IA
    (2007) Developmental expression of the G protein-coupled receptor 54 and three GnRH mRNAs in the teleost fish cobia. J Mol Endocrinol 38:235–244.
    OpenUrlAbstract/FREE Full Text
  101. ↵
    1. Moon JS,
    2. Lee YR,
    3. Oh DY,
    4. Hwang JI,
    5. Lee JY,
    6. Kim JI,
    7. Vaudry H,
    8. Kwon HB,
    9. Seong JY
    (2009) Molecular cloning of the bullfrog kisspeptin receptor GPR54 with high sensitivity to Xenopus kisspeptin. Peptides 30:171–179.
    OpenUrlCrossRefPubMed
  102. ↵
    1. Muir AI,
    2. Chamberlain L,
    3. Elshourbagy NA,
    4. Michalovich D,
    5. Moore DJ,
    6. Calamari A,
    7. Szekeres PG,
    8. Sarau HM,
    9. Chambers JK,
    10. Murdock P,
    11. et al
    . (2001) AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem 276:28969–28975.
    OpenUrlAbstract/FREE Full Text
  103. ↵
    1. Navarro VM,
    2. Castellano JM,
    3. Fernández-Fernández R,
    4. Barreiro ML,
    5. Roa J,
    6. Sanchez-Criado JE,
    7. Aguilar E,
    8. Dieguez C,
    9. Pinilla L,
    10. Tena-Sempere M.,
    11. Pinilla L,
    12. Tena-Sempere M
    (2004a) Developmental and hormonally regulated messenger ribonucleic acid expression of KiSS-1 and its putative receptor, GPR54, in rat hypothalamus and potent luteinizing hormone-releasing activity of KiSS-1 peptide. Endocrinology 145:4565–4574.
    OpenUrlCrossRefPubMed
  104. ↵
    1. Navarro VM,
    2. Castellano JM,
    3. Fernández-Fernández R,
    4. Tovar S,
    5. Roa J,
    6. Mayen A,
    7. Barreiro ML,
    8. Casanueva FF,
    9. Aguilar E,
    10. Dieguez C,
    11. et al
    . (2005a) Effects of KiSS-1 peptide, the natural ligand of GPR54, on follicle-stimulating hormone secretion in the rat. Endocrinology 146:1689–1697.
    OpenUrlCrossRefPubMed
  105. ↵
    1. Navarro VM,
    2. Castellano JM,
    3. Fernández-Fernández R,
    4. Tovar S,
    5. Roa J,
    6. Mayen A,
    7. Nogueiras R,
    8. Vazquez MJ,
    9. Barreiro ML,
    10. Magni P,
    11. et al
    . (2005b) Characterization of the potent luteinizing hormone-releasing activity of KiSS-1 peptide, the natural ligand of GPR54. Endocrinology 146:156–163.
    OpenUrlCrossRefPubMed
  106. ↵
    1. Navarro VM,
    2. Castellano JM,
    3. García-Galiano D,
    4. Tena-Sempere M
    (2007) Neuroendocrine factors in the initiation of puberty: the emergent role of kisspeptin. Rev Endocr Metab Disord 8:11–20.
    OpenUrlCrossRefPubMed
  107. ↵
    1. Navarro VM,
    2. Fernández-Fernández R,
    3. Castellano JM,
    4. Roa J,
    5. Mayen A,
    6. Barreiro ML,
    7. Gaytan F,
    8. Aguilar E,
    9. Pinilla L,
    10. Dieguez C,
    11. et al
    . (2004b) Advanced vaginal opening and precocious activation of the reproductive axis by KiSS-1 peptide, the endogenous ligand of GPR54. J Physiol 561:379–386.
    OpenUrlCrossRefPubMed
  108. ↵
    1. Navenot JM,
    2. Fujii N,
    3. Peiper SC
    (2009a) Activation of Rho and Rho-associated kinase by GPR54 and KiSS1 metastasis suppressor gene product induces changes of cell morphology and contributes to apoptosis. Mol Pharmacol 75:1300–1306.
    OpenUrlAbstract/FREE Full Text
  109. ↵
    1. Navenot JM,
    2. Fujii N,
    3. Peiper SC
    (2009b) KiSS1 metastasis suppressor gene product induces suppression of tyrosine kinase receptor signaling to Akt, tumor necrosis factor family ligand expression, and apoptosis. Mol Pharmacol 75:1074–1083.
    OpenUrlAbstract/FREE Full Text
  110. ↵
    1. Navenot JM,
    2. Wang Z,
    3. Chopin M,
    4. Fujii N,
    5. Peiper SC
    (2005) Kisspeptin-10-induced signaling of GPR54 negatively regulates chemotactic responses mediated by CXCR4: a potential mechanism for the metastasis suppressor activity of kisspeptins. Cancer Res 65:10450–10456.
    OpenUrlAbstract/FREE Full Text
  111. ↵
    1. Niida A,
    2. Wang Z,
    3. Tomita K,
    4. Oishi S,
    5. Tamamura H,
    6. Otaka A,
    7. Navenot JM,
    8. Broach JR,
    9. Peiper SC,
    10. Fujii N
    (2006) Design and synthesis of downsized metastin (45–54) analogs with maintenance of high GPR54 agonistic activity. Bioorg Med Chem Lett 16:134–137.
    OpenUrlCrossRefPubMed
  112. ↵
    1. Nocillado JN,
    2. Levavi-Sivan B,
    3. Carrick F,
    4. Elizur A
    (2007) Temporal expression of G-protein-coupled receptor 54 (GPR54), gonadotropin-releasing hormones (GnRH), and dopamine receptor D2 (drd2) in pubertal female grey mullet, Mugil cephalus. Gen Comp Endocrinol 150:278–287.
    OpenUrlCrossRefPubMed
  113. ↵
    1. Oakley AE,
    2. Clifton DK,
    3. Steiner RA
    (2009) Kisspeptin signaling in the brain. Endocr Rev 30:713–743.
    OpenUrlCrossRefPubMed
  114. ↵
    1. Ohkura S,
    2. Takase K,
    3. Matsuyama S,
    4. Mogi K,
    5. Ichimaru T,
    6. Wakabayashi Y,
    7. Uenoyama Y,
    8. Mori Y,
    9. Steiner RA,
    10. Tsukamura H,
    11. et al
    . (2009) Gonadotrophin-releasing hormone pulse generator activity in the hypothalamus of the goat. J Neuroendocrinol 21:813–821.
    OpenUrlCrossRefPubMed
  115. ↵
    1. Ohtaki T,
    2. Shintani Y,
    3. Honda S,
    4. Matsumoto H,
    5. Hori A,
    6. Kanehashi K,
    7. Terao Y,
    8. Kumano S,
    9. Takatsu Y,
    10. Masuda Y,
    11. et al
    . (2001) Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 411:613–617.
    OpenUrlCrossRefPubMed
  116. ↵
    1. Orsini MJ,
    2. Klein MA,
    3. Beavers MP,
    4. Connolly PJ,
    5. Middleton SA,
    6. Mayo KH
    (2007) Metastin (KiSS-1) mimetics identified from peptide structure-activity relationship-derived pharmacophores and directed small molecule database screening. J Med Chem 50:462–471.
    OpenUrlCrossRefPubMed
  117. ↵
    1. Pampillo M,
    2. Camuso N,
    3. Taylor JE,
    4. Szereszewski JM,
    5. Ahow MR,
    6. Zajac M,
    7. Millar RP,
    8. Bhattacharya M,
    9. Babwah AV
    (2009) Regulation of GPR54 signaling by GRK2 and beta-arrestin. Mol Endocrinol 23:2060–2074.
    OpenUrlCrossRefPubMed
  118. ↵
    1. Panidis D,
    2. Rousso D,
    3. Koliakos G,
    4. Kourtis A,
    5. Katsikis I,
    6. Farmakiotis D,
    7. Votsi E,
    8. Diamanti-Kandarakis E
    (2006) Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome. Fertil Steril 85:1778–1783.
    OpenUrlCrossRefPubMed
  119. ↵
    1. Parhar IS,
    2. Ogawa S,
    3. Sakuma Y
    (2004) Laser-captured single digoxigenin-labeled neurons of gonadotropin-releasing hormone types reveal a novel G protein-coupled receptor (Gpr54) during maturation in cichlid fish. Endocrinology 145:3613–3618.
    OpenUrlCrossRefPubMed
  120. ↵
    1. Paul MJ,
    2. Pyter LM,
    3. Freeman DA,
    4. Galang J,
    5. Prendergast BJ
    (2009) Photic and nonphotic seasonal cues differentially engage hypothalamic kisspeptin and RFamide-related peptide mRNA expression in Siberian hamsters. J Neuroendocrinol 21:1007–1014.
    OpenUrlCrossRefPubMed
  121. ↵
    1. Pheng V,
    2. Uenoyama Y,
    3. Homma T,
    4. Inamoto Y,
    5. Takase K,
    6. Yoshizawa-Kumagaye K,
    7. Isaka S,
    8. Watanabe TX,
    9. Ohkura S,
    10. Tomikawa J,
    11. et al
    . (2009) Potencies of centrally- or peripherally-injected full-length kisspeptin or its C-terminal decapeptide on LH release in intact male rats. J Reprod Dev 55:378–382.
    OpenUrlCrossRefPubMed
  122. ↵
    1. Pielecka-Fortuna J,
    2. Chu Z,
    3. Moenter SM
    (2008) Kisspeptin acts directly and indirectly to increase gonadotropin-releasing hormone neuron activity and its effects are modulated by estradiol. Endocrinology 149:1979–1986.
    OpenUrlCrossRefPubMed
  123. ↵
    1. Pineda R,
    2. Garcia-Galiano D,
    3. Roseweir A,
    4. Romero M,
    5. Sanchez-Garrido MA,
    6. Ruiz-Pino F,
    7. Morgan K,
    8. Pinilla L,
    9. Millar RP,
    10. Tena-Sempere M
    (2010) Critical roles of kisspeptins in female puberty and preovulatory gonadotropin surges as revealed by a novel antagonist. Endocrinology 151:722–730.
    OpenUrlCrossRefPubMed
  124. ↵
    1. Plant TM,
    2. Ramaswamy S,
    3. Dipietro MJ
    (2006) Repetitive activation of hypothalamic G protein-coupled receptor 54 with intravenous pulses of kisspeptin in the juvenile monkey (Macaca mulatta) elicits a sustained train of gonadotropin-releasing hormone discharges. Endocrinology 147:1007–1013.
    OpenUrlCrossRefPubMed
  125. ↵
    1. Pompolo S,
    2. Pereira A,
    3. Estrada KM,
    4. Clarke IJ
    (2006) Colocalization of kisspeptin and gonadotropin-releasing hormone in the ovine brain. Endocrinology 147:804–810.
    OpenUrlCrossRefPubMed
  126. ↵
    1. Qiao C,
    2. Wang CH,
    3. Shang T,
    4. Lin QD
    (2005) [Clinical significance of KiSS-1 and matrix metalloproteinase-9 expression in trophoblasts of women with preeclampsia and their relation to perinatal outcome of neonates.] Zhonghua Fu Chan Ke Za Zhi 40:585–590.
    OpenUrlPubMed
  127. ↵
    1. Quaynor S,
    2. Hu L,
    3. Leung PK,
    4. Feng H,
    5. Mores N,
    6. Krsmanovic LZ,
    7. Catt KJ
    (2007) Expression of a functional G protein-coupled receptor 54-kisspeptin autoregulatory system in hypothalamic gonadotropin-releasing hormone neurons. Mol Endocrinol 21:3062–3070.
    OpenUrlCrossRefPubMed
  128. ↵
    1. Ramaswamy S,
    2. Gibbs RB,
    3. Plant TM
    (2009) Studies of the localisation of kisspeptin within the pituitary of the rhesus monkey (Macaca mulatta) and the effect of kisspeptin on the release of non-gonadotropic pituitary hormones. J Neuroendocrinol 21:795–804.
    OpenUrlCrossRefPubMed
  129. ↵
    1. Ramaswamy S,
    2. Guerriero KA,
    3. Gibbs RB,
    4. Plant TM
    (2008) Structural interactions between kisspeptin and GnRH neurons in the mediobasal hypothalamus of the male rhesus monkey (Macaca mulatta) as revealed by double immunofluorescence and confocal microscopy. Endocrinology 149:4387–4395.
    OpenUrlCrossRefPubMed
  130. ↵
    1. Ramaswamy S,
    2. Seminara SB,
    3. Pohl CR,
    4. DiPietro MJ,
    5. Crowley WF Jr.,
    6. Plant TM
    (2007) Effect of continuous intravenous administration of human metastin 45-54 on the neuroendocrine activity of the hypothalamic-pituitary-testicular axis in the adult male rhesus monkey (Macaca mulatta). Endocrinology 148:3364–3370.
    OpenUrlCrossRefPubMed
  131. ↵
    1. Revel FG,
    2. Ansel L,
    3. Klosen P,
    4. Saboureau M,
    5. Pévet P,
    6. Mikkelsen JD,
    7. Simonneaux V
    (2007) Kisspeptin: a key link to seasonal breeding. Rev Endocr Metab Disord 8:57–65.
    OpenUrlCrossRefPubMed
  132. ↵
    1. Reynolds RM,
    2. Logie JJ,
    3. Roseweir AK,
    4. McKnight AJ,
    5. Millar RP
    (2009) A role for kisspeptins in pregnancy: facts and speculations. Reproduction 138:1–7.
    OpenUrlAbstract/FREE Full Text
  133. ↵
    1. Richard N,
    2. Corvaisier S,
    3. Camacho E,
    4. Kottler ML
    (2009) KiSS-1 and GPR54 at the pituitary level: overview and recent insights. Peptides 30:123–129.
    OpenUrlCrossRefPubMed
  134. ↵
    1. Richard N,
    2. Galmiche G,
    3. Corvaisier S,
    4. Caraty A,
    5. Kottler ML
    (2008) KiSS-1 and GPR54 genes are co-expressed in rat gonadotrophs and differentially regulated in vivo by oestradiol and gonadotrophin-releasing hormone. J Neuroendocrinol 20:381–393.
    OpenUrlCrossRefPubMed
  135. ↵
    1. Ringel MD,
    2. Hardy E,
    3. Bernet VJ,
    4. Burch HB,
    5. Schuppert F,
    6. Burman KD,
    7. Saji M
    (2002) Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells. J Clin Endocrinol Metab 87:2399–2402.
    OpenUrlCrossRefPubMed
  136. ↵
    1. Roa J,
    2. Castellano JM,
    3. Navarro VM,
    4. Handelsman DJ,
    5. Pinilla L,
    6. Tena-Sempere M
    (2009) Kisspeptins and the control of gonadotropin secretion in male and female rodents. Peptides 30:57–66.
    OpenUrlCrossRefPubMed
  137. ↵
    1. Roa J,
    2. Vigo E,
    3. García-Galiano D,
    4. Castellano JM,
    5. Navarro VM,
    6. Pineda R,
    7. Diéguez C,
    8. Aguilar E,
    9. Pinilla L,
    10. Tena-Sempere M
    (2008a) Desensitization of gonadotropin responses to kisspeptin in the female rat: analyses of LH and FSH secretion at different developmental and metabolic states. Am J Physiol Endocrinol Metab 294:E1088–E1096.
    OpenUrlAbstract/FREE Full Text
  138. ↵
    1. Roa J,
    2. Vigo E,
    3. Castellano JM,
    4. Gaytan F,
    5. García-Galiano D,
    6. Navarro VM,
    7. Aguilar E,
    8. Dijcks FA,
    9. Ederveen AG,
    10. Pinilla L,
    11. et al
    . (2008b) Follicle-stimulating hormone responses to kisspeptin in the female rat at the preovulatory period: modulation by estrogen and progesterone receptors. Endocrinology 149:5783–5790.
    OpenUrlCrossRefPubMed
  139. ↵
    1. Roa J,
    2. Vigo E,
    3. Castellano JM,
    4. Gaytan F,
    5. Navarro VM,
    6. Aguilar E,
    7. Dijcks FA,
    8. Ederveen AG,
    9. Pinilla L,
    10. van Noort PI,
    11. et al
    . (2008c) Opposite roles of estrogen receptor (ER)-alpha and ERbeta in the modulation of luteinizing hormone responses to kisspeptin in the female rat: implications for the generation of the preovulatory surge. Endocrinology 149:1627–1637.
    OpenUrlCrossRefPubMed
  140. ↵
    1. Rometo AM,
    2. Krajewski SJ,
    3. Voytko ML,
    4. Rance NE
    (2007) Hypertrophy and increased kisspeptin gene expression in the hypothalamic infundibular nucleus of postmenopausal women and ovariectomized monkeys. J Clin Endocrinol Metab 92:2744–2750.
    OpenUrlCrossRefPubMed
  141. ↵
    1. Roseweir AK,
    2. Kauffman AS,
    3. Smith JT,
    4. Guerriero KA,
    5. Morgan K,
    6. Pielecka-Fortuna J,
    7. Pineda R,
    8. Gottsch ML,
    9. Tena-Sempere M,
    10. Moenter SM,
    11. et al
    . (2009) Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation. J Neurosci 29:3920–3929.
    OpenUrlAbstract/FREE Full Text
  142. ↵
    1. Sanchez-Carbayo M,
    2. Belbin TJ,
    3. Scotlandi K,
    4. Prystowsky M,
    5. Baldini N,
    6. Childs G,
    7. Cordon-Cardo C
    (2003) Expression profiling of osteosarcoma cells transfected with MDR1 and NEO genes: regulation of cell adhesion, apoptosis, and tumor suppression-related genes. Lab Invest 83:507–517.
    OpenUrlPubMed
  143. ↵
    1. Schmid K,
    2. Wang X,
    3. Haitel A,
    4. Sieghart W,
    5. Peck-Radosavljevic M,
    6. Bodingbauer M,
    7. Rasoul-Rockenschaub S,
    8. Wrba F
    (2007) KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study. Virchows Arch 450:143–149.
    OpenUrlCrossRefPubMed
  144. ↵
    1. Seminara SB
    (2006) Mechanisms of Disease: the first kiss-a crucial role for kisspeptin-1 and its receptor, G-protein-coupled receptor 54, in puberty and reproduction. Nat Clin Pract Endocrinol Metab 2:328–334.
    OpenUrlCrossRefPubMed
  145. ↵
    1. Seminara SB,
    2. Dipietro MJ,
    3. Ramaswamy S,
    4. Crowley WF Jr.,
    5. Plant TM
    (2006) Continuous human metastin 45–54 infusion desensitizes G protein-coupled receptor 54-induced gonadotropin-releasing hormone release monitored indirectly in the juvenile male Rhesus monkey (Macaca mulatta): a finding with therapeutic implications. Endocrinology 147:2122–2126.
    OpenUrlCrossRefPubMed
  146. ↵
    1. Seminara SB,
    2. Messager S,
    3. Chatzidaki EE,
    4. Thresher RR,
    5. Acierno JS Jr..,
    6. Shagoury JK,
    7. Bo-Abbas Y,
    8. Kuohung W,
    9. Schwinof KM,
    10. Hendrick AG,
    11. Zahn D,
    12. Dixon J,
    13. Kaiser UB,
    14. Slaugenhaupt SA,
    15. Gusella JF,
    16. O'Rahilly S,
    17. Carlton MB,
    18. Crowley WF Jr..,
    19. Aparicio SA,
    20. Colledge WH
    (2003) The GPR54 gene as a regulator of puberty. N Engl J Med 349:1614–1627.
    OpenUrlCrossRefPubMed
  147. ↵
    1. Shahab M,
    2. Mastronardi C,
    3. Seminara SB,
    4. Crowley WF,
    5. Ojeda SR,
    6. Plant TM
    (2005) Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primates. Proc Natl Acad Sci USA 102:2129–2134.
    OpenUrlAbstract/FREE Full Text
  148. ↵
    1. Shibata M,
    2. Friedman RL,
    3. Ramaswamy S,
    4. Plant TM
    (2007) Evidence that down regulation of hypothalamic KiSS-1 expression is involved in the negative feedback action of testosterone to regulate luteinising hormone secretion in the adult male rhesus monkey (Macaca mulatta). J Neuroendocrinol 19:432–438.
    OpenUrlCrossRefPubMed
  149. ↵
    1. Shirasaki F,
    2. Takata M,
    3. Hatta N,
    4. Takehara K
    (2001) Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. Cancer Res 61:7422–7425.
    OpenUrlAbstract/FREE Full Text
  150. ↵
    1. Silvestre RA,
    2. Egido EM,
    3. Hernández R,
    4. Marco J
    (2008) Kisspeptin-13 inhibits insulin secretion without affecting glucagon or somatostatin release: study in the perfused rat pancreas. J Endocrinol 196:283–290.
    OpenUrlAbstract/FREE Full Text
  151. ↵
    1. Simonneaux V,
    2. Ansel L,
    3. Revel FG,
    4. Klosen P,
    5. Pévet P,
    6. Mikkelsen JD
    (2009) Kisspeptin and the seasonal control of reproduction in hamsters. Peptides 30:146–153.
    OpenUrlCrossRefPubMed
  152. ↵
    1. Smith JT,
    2. Acohido BV,
    3. Clifton DK,
    4. Steiner RA
    (2006a) KiSS-1 neurones are direct targets for leptin in the ob/ob mouse. J Neuroendocrinol 18:298–303.
    OpenUrlCrossRefPubMed
  153. ↵
    1. Smith JT,
    2. Clarke IJ
    (2007) Kisspeptin expression in the brain: catalyst for the initiation of puberty. Rev Endocr Metab Disord 8:1–9.
    OpenUrlCrossRefPubMed
  154. ↵
    1. Smith JT,
    2. Clay CM,
    3. Caraty A,
    4. Clarke IJ
    (2007) KiSS-1 messenger ribonucleic acid expression in the hypothalamus of the ewe is regulated by sex steroids and season. Endocrinology 148:1150–1157.
    OpenUrlCrossRefPubMed
  155. ↵
    1. Smith JT,
    2. Coolen LM,
    3. Kriegsfeld LJ,
    4. Sari IP,
    5. Jaafarzadehshirazi MR,
    6. Maltby M,
    7. Bateman K,
    8. Goodman RL,
    9. Tilbrook AJ,
    10. Ubuka T,
    11. et al
    . (2008) Variation in kisspeptin and RFamide-related peptide (RFRP) expression and terminal connections to gonadotropin-releasing hormone neurons in the brain: a novel medium for seasonal breeding in the sheep. Endocrinology 149:5770–5782.
    OpenUrlCrossRefPubMed
  156. ↵
    1. Smith JT,
    2. Cunningham MJ,
    3. Rissman EF,
    4. Clifton DK,
    5. Steiner RA
    (2005a) Regulation of Kiss1 gene expression in the brain of the female mouse. Endocrinology 146:3686–3692.
    OpenUrlCrossRefPubMed
  157. ↵
    1. Smith JT,
    2. Dungan HM,
    3. Stoll EA,
    4. Gottsch ML,
    5. Braun RE,
    6. Eacker SM,
    7. Clifton DK,
    8. Steiner RA
    (2005b) Differential regulation of KiSS-1 mRNA expression by sex steroids in the brain of the male mouse. Endocrinology 146:2976–2984.
    OpenUrlCrossRefPubMed
  158. ↵
    1. Smith JT,
    2. Popa SM,
    3. Clifton DK,
    4. Hoffman GE,
    5. Steiner RA
    (2006b) Kiss1 neurons in the forebrain as central processors for generating the preovulatory luteinizing hormone surge. J Neurosci 26:6687–6694.
    OpenUrlAbstract/FREE Full Text
  159. ↵
    1. Stafford LJ,
    2. Xia C,
    3. Ma W,
    4. Cai Y,
    5. Liu M
    (2002) Identification and characterization of mouse metastasis-suppressor KiSS1 and its G-protein-coupled receptor. Cancer Res 62:5399–5404.
    OpenUrlAbstract/FREE Full Text
  160. ↵
    1. Stark AM,
    2. Tongers K,
    3. Maass N,
    4. Mehdorn HM,
    5. Held-Feindt J
    (2005) Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. J Cancer Res Clin Oncol 131:191–198.
    OpenUrlCrossRefPubMed
  161. ↵
    1. Stathatos N,
    2. Bourdeau I,
    3. Espinosa AV,
    4. Saji M,
    5. Vasko VV,
    6. Burman KD,
    7. Stratakis CA,
    8. Ringel MD
    (2005) KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity. J Clin Endocrinol Metab 90:5432–5440.
    OpenUrlCrossRefPubMed
  162. ↵
    1. Takino T,
    2. Koshikawa N,
    3. Miyamori H,
    4. Tanaka M,
    5. Sasaki T,
    6. Okada Y,
    7. Seiki M,
    8. Sato H
    (2003) Cleavage of metastasis suppressor gene product KiSS-1 protein/metastin by matrix metalloproteinases. Oncogene 22:4617–4626.
    OpenUrlCrossRefPubMed
  163. ↵
    1. Teles MG,
    2. Bianco SD,
    3. Brito VN,
    4. Trarbach EB,
    5. Kuohung W,
    6. Xu S,
    7. Seminara SB,
    8. Mendonca BB,
    9. Kaiser UB,
    10. Latronico AC
    (2008) A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med 358:709–715.
    OpenUrlCrossRefPubMed
  164. ↵
    1. Tena-Sempere M
    (2006a) GPR54 and kisspeptin in reproduction. Hum Reprod Update 12:631–639.
    OpenUrlAbstract/FREE Full Text
  165. ↵
    1. Tena-Sempere M
    (2006b) The roles of kisspeptins and G protein-coupled receptor-54 in pubertal development. Curr Opin Pediatr 18:442–447.
    OpenUrlPubMed
  166. ↵
    1. Terao Y,
    2. Kumano S,
    3. Takatsu Y,
    4. Hattori M,
    5. Nishimura A,
    6. Ohtaki T,
    7. Shintani Y
    (2004) Expression of KiSS-1, a metastasis suppressor gene, in trophoblast giant cells of the rat placenta. Biochim Biophys Acta 1678:102–110.
    OpenUrlPubMed
  167. ↵
    1. Thompson EL,
    2. Amber V,
    3. Stamp GW,
    4. Patterson M,
    5. Curtis AE,
    6. Cooke JH,
    7. Appleby GF,
    8. Dhillo WS,
    9. Ghatei MA,
    10. Bloom SR,
    11. et al
    . (2009) Kisspeptin-54 at high doses acutely induces testicular degeneration in adult male rats via central mechanisms. Br J Pharmacol 156:609–625.
    OpenUrlCrossRefPubMed
  168. ↵
    1. Thompson EL,
    2. Murphy KG,
    3. Patterson M,
    4. Bewick GA,
    5. Stamp GW,
    6. Curtis AE,
    7. Cooke JH,
    8. Jethwa PH,
    9. Todd JF,
    10. Ghatei MA,
    11. et al
    . (2006) Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats. Am J Physiol Endocrinol Metab 291:E1074–E1082.
    OpenUrlAbstract/FREE Full Text
  169. ↵
    1. Thompson EL,
    2. Patterson M,
    3. Murphy KG,
    4. Smith KL,
    5. Dhillo WS,
    6. Todd JF,
    7. Ghatei MA,
    8. Bloom SR
    (2004) Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol 16:850–858.
    OpenUrlCrossRefPubMed
  170. ↵
    1. Tomikawa J,
    2. Homma T,
    3. Tajima S,
    4. Shibata T,
    5. Inamoto Y,
    6. Takase K,
    7. Inoue N,
    8. Ohkura S,
    9. Uenoyama Y,
    10. Maeda K,
    11. et al
    . (2010) Molecular characterization and estrogen regulation of hypothalamic KISS1 gene in the pig. Biol Reprod 82:313–319.
    OpenUrlAbstract/FREE Full Text
  171. ↵
    1. Tomita K,
    2. Narumi T,
    3. Niida A,
    4. Oishi S,
    5. Ohno H,
    6. Fujii N
    (2007) Fmoc-based solid-phase synthesis of GPR54-agonistic pentapeptide derivatives containing alkene- and fluoroalkene-dipeptide isosteres. Biopolymers 88:272–278.
    OpenUrlCrossRefPubMed
  172. ↵
    1. Tomita K,
    2. Niida A,
    3. Oishi S,
    4. Ohno H,
    5. Cluzeau J,
    6. Navenot JM,
    7. Wang ZX,
    8. Peiper SC,
    9. Fujii N
    (2006) Structure-activity relationship study on small peptidic GPR54 agonists. Bioorg Med Chem 14:7595–7603.
    OpenUrlPubMed
  173. ↵
    1. Tomita K,
    2. Oishi S,
    3. Ohno H,
    4. Fujii N
    (2008) Structure-activity relationship study and NMR analysis of fluorobenzoyl pentapeptide GPR54 agonists. Biopolymers 90:503–511.
    OpenUrlCrossRefPubMed
  174. ↵
    1. van Aerle R,
    2. Kille P,
    3. Lange A,
    4. Tyler CR
    (2008) Evidence for the existence of a functional Kiss1/Kiss1 receptor pathway in fish. Peptides 29:57–64.
    OpenUrlCrossRefPubMed
  175. ↵
    1. Vanhoutte PM,
    2. Humphrey PP,
    3. Spedding M
    (1996) X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes. Pharmacol Rev 48:1–2.
    OpenUrlPubMed
  176. ↵
    1. Wacker JL,
    2. Feller DB,
    3. Tang XB,
    4. Defino MC,
    5. Namkung Y,
    6. Lyssand JS,
    7. Mhyre AJ,
    8. Tan X,
    9. Jensen JB,
    10. Hague C
    (2008) Disease-causing mutation in GPR54 reveals the importance of the second intracellular loop for class A G-protein-coupled receptor function. J Biol Chem 283:31068–31078.
    OpenUrlAbstract/FREE Full Text
  177. ↵
    1. Wagner GC,
    2. Johnston JD,
    3. Clarke IJ,
    4. Lincoln GA,
    5. Hazlerigg DG
    (2008) Redefining the limits of day length responsiveness in a seasonal mammal. Endocrinology 149:32–39.
    OpenUrlCrossRefPubMed
  178. ↵
    1. Welch DR,
    2. Chen P,
    3. Miele ME,
    4. McGary CT,
    5. Bower JM,
    6. Stanbridge EJ,
    7. Weissman BE
    (1994) Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene 9:255–262.
    OpenUrlPubMed
  179. ↵
    1. West A,
    2. Vojta PJ,
    3. Welch DR,
    4. Weissman BE
    (1998) Chromosome localization and genomic structure of the KiSS-1 metastasis suppressor gene (KISS1). Genomics 54:145–148.
    OpenUrlCrossRefPubMed
  180. ↵
    1. Yan C,
    2. Wang H,
    3. Boyd DD
    (2001) KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha -induced block of p65/p50 nuclear translocation. J Biol Chem 276:1164–1172.
    OpenUrlAbstract/FREE Full Text
  181. ↵
    1. Yang B,
    2. Jiang Q,
    3. Chan T,
    4. Ko WK,
    5. Wong AO
    (2010) Goldfish kisspeptin: molecular cloning, tissue distribution of transcript expression, and stimulatory effects on prolactin, growth hormone and luteinizing hormone secretion and gene expression via direct actions at the pituitary level. Gen Comp Endocrinol 165: 60–71.
    OpenUrlCrossRefPubMed
  182. ↵
    1. Yao HL,
    2. Yang ZL,
    3. Li YG,
    4. Liu GW
    (2007) [In situ hybridization study on the expression of Kiss-1 and KAI-1 metastasis suppressor genes in gastric cancer.] Zhonghua Wei Chang Wai Ke Za Zhi 10:274–277.
    OpenUrlPubMed
  183. ↵
    1. Zhang C,
    2. Roepke TA,
    3. Kelly MJ,
    4. Rønnekleiv OK
    (2008) Kisspeptin depolarizes gonadotropin-releasing hormone neurons through activation of TRPC-like cationic channels. J Neurosci 28:4423–4434.
    OpenUrlAbstract/FREE Full Text
  184. ↵
    1. Zhang SL,
    2. Yu Y,
    3. Jiang T,
    4. Lin B,
    5. Gao H
    (2005) [Expression and significance of KiSS-1 and its receptor GPR54 mRNA in epithelial ovarian cancer.] Zhonghua Fu Chan Ke Za Zhi 40:689–692.
    OpenUrlPubMed
  185. ↵
    1. Zohrabian VM,
    2. Nandu H,
    3. Gulati N,
    4. Khitrov G,
    5. Zhao C,
    6. Mohan A,
    7. Demattia J,
    8. Braun A,
    9. Das K,
    10. Murali R,
    11. et al
    . (2007) Gene expression profiling of metastatic brain cancer. Oncol Rep 18:321–328.
    OpenUrlPubMed
View Abstract
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleIUPHAR Nomenclature Reports

International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin Receptor Nomenclature, Distribution, and Function

Helen R. Kirby, Janet J. Maguire, William H. Colledge and Anthony P. Davenport
Pharmacological Reviews December 1, 2010, 62 (4) 565-578; DOI: https://doi.org/10.1124/pr.110.002774
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement